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Abstract
Age-related macular degeneration (AMD) is a chronic, irreversible disease that robs
individuals of vision, quality of life, and independence. It is the leading cause of
blindness in industrialized countries. Sleep-disordered breathing (SDB) is a condition
characterized by repeated episodes of apnea and/or hypopnea, insomnia, short sleep
duration, and/or sleep disturbances (snoring, gasping, etc.). Because SDB has been shown
to cause chronic hypoxia resulting in oxidative stress on the retina, it has been proposed
that SDB may be associated with AMD. Based on the life course theory of chronic
disease, this quantitative, cross-sectional study used data from the 2005–2008 National
Health and Nutrition Examination Survey to study whether there was an association
between SDB and AMD, including neovascular AMD and geographic atrophy in adults
40 years and older. Descriptive statistics and logistic regression analyses were used. The
results suggest that AMD is associated with diagnosed sleep disorders, including sleep
apnea and insomnia, as well as sleep apnea symptoms of gasping snoring, snorting, and
stopping breathing. The findings of this study highlight the importance of diagnostic
screening and therapeutic intervention to treat SDB. Early diagnosis and therapy for SDB
could address not only the comorbidities associated with SDB, but could also prevent or
slow the progression of AMD. In turn, this would yield lower rates of vision loss, reduced
comorbidities associated with vision loss, and reduced impact of AMD on the health care
system and social and financial costs to society.
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Chapter 1: Introduction to the Study
Introduction
The World Health Organization (WHO) ranks age-related macular degeneration
(AMD) as the third leading cause of blindness globally behind cataracts and glaucoma
and the leading cause of blindness in industrialized countries (World Health Organization
[WHO], 2015). . By the year 2050, the estimate of people with AMD is expected to more
than double from 2.07 million to 5.44 million (National Eye Institute, 2016a). Although
the clinical understanding of AMD is continually evolving, the precise etiology of the
disease remains elusive. A recently emerging area of interest is the impact of sleep and/or
sleep-disordered breathing (SDB) on the development and treatment of AMD (Khurana
et al., 2016). Currently, there exists a knowledge gap which this research was designed to
address.
SDB is a condition whereby episodes of cessation of breathing or apnea are
repeated and/or an abnormally shallow rate of respiration (hypopnea) occurs (Peppard et
al., 2013) . This disruption can be caused by complete or partial obstructions to the
airway, known as obstructive sleep apnea, or by disorders such as chronic sinusitis,
allergies, and obesity (Balachandran & Patel, 2014). It is estimated that 14% of males and
5% of females in the United States meet the Medicare criteria for obstructive sleep apnea,
which is an apnea/hypopnea score greater than 5, plus symptoms of daytime sleepiness
(Peppard et al., 2013). Systematic monitoring of SDB is not currently performed in the
United States because it is costly and time-consuming (Peppard et al., 2013). Therefore,
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the prevalence of SDB may be underestimated and undiagnosed subjects may be at risk
for its serious long-term complications.
Findings of this research could reinforce the need for diagnostic screening and
therapeutic intervention to treat SDB. Early diagnosis and initiation of therapy for SDB
would not only address the comorbidities associated with SDB, but may also prevent or
slow the progression of AMD. Preventing or slowing the progression of AMD may result
in lower rates of vision loss and reduced comorbidities associated with vision loss. In
turn, this would help reduce the impact of AMD on the health care system and overall
costs to society.
In this chapter, I describe the following components of the study: background;
problem statement; purpose; research questions and hypotheses; nature of the study;
conceptual framework; assumptions, scope and delimitations, limitations; and
significance.
Background
AMD is a disease of the retina that causes photoreceptor degeneration (W. Wong
et al., 2014). Currently, there are few effective preventive measures available to patients,
for example, dietary supplements and smoking cessation, (Glaser et al., 2015). It was
estimated in the year 2000 that AMD affected 1.75 million individuals in the United
States (Friedman et al., 2004). This number has increased to 2.07 million in the decade
since (NEI, 2016a). AMD exists in both dry and wet forms. The dry form is characterized
by a slow degeneration of photoreceptors and the wet or neovascular AMD (nAMD)
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form identified by the formation of new blood vessels in an area of the retina that is
normally avascular (Leibowitz et al., 1980). Data from the 2005–2008 National Health
and Nutrition Examination Survey (NHANES) estimated that the overall prevalence of
AMD in the U.S. population was 6.5% (Klein et al., 2011). Joachim, Mitchell, Burlutsky,
Kifley, and Wang (2015) provided estimates from the Blue Mountain Eye Study in
Australia. They wrote that the 15-year incidence was 22.7% for early AMD and 6.8% for
late (neovascular) AMD in subjects older than 49 years. Currently, the only therapy
shown to have a preventive benefit for dry AMD is a combination of antioxidant
supplements (Age-Related Eye Disease Study 2 Research Group, 2013). Treatment for
the neovascular form of AMD was thought to have been revolutionized by the advent of
anti-vascular endothelial growth factor (VEGF) therapy, although long-term outcomes
have shown that the therapy is not sustainable and most patients do not achieve functional
vision outcomes (Brown et al., 2006; Heier et al., 2012; Kaiser et al., 2007; Rasmussen et
al., 2013; Schmidt-Erfurth et al., 2014).
Research into risk factors associated with AMD has provided information on a
number of variables that include age, smoking (Myers et al., 2014; Thornton et al., 2005;
Velilla et al., 2013), race and/or ethnicity (Klein, Li, et al., 2013; W. Wong et al., 2014),
family history (Seddon, Cote, Page, Aggen, & Neale, 2005), obesity (Clemons et al.,
2005), and a growing number of genetic mutations (Kanda et al., 2007; Klein, Myers, et
al., 2013; Seddon et al., 2007; Triebwasser et al., 2015; van Lookeren Campagne,
LeCouter, Yaspan, & Ye, 2014). Genetic studies have shown that inheritable mutations
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may account for up to 70% of the risk for AMD and those that have been shown to be
most strongly associated include the complement factor H (CFH) and the age-related
maculopathy susceptibility 2/High Temperature Requirement A Serine Peptidase 1
(ARMS2/HTRA1) genes (Kanda et al., 2007; Seddon et al., 2007)
The landmark Wisconsin Sleep Cohort study estimated the prevalence of SDB in
30–60-year-old subjects , who were currently employed at 9% in women and 24% in men
(T. Young et al., 1993). The Wisconsin Sleep Cohort study has since been followed
longitudinally to estimate the prevalence of SDB in the United States during the periods
of 1988-1994 and 2007-2010 (Peppard et al., 2013). The prevalence of SDB in 20072010 was 10% among 30-49 year old men; 17% among 50-70 year old men; 3% among
30-49 year old women; and 9% among 50-70 year old women (Peppard et al., 2013). The
authors estimated that prevalence since the period 1988-1994 has increased between 14%
and 55%, depending upon the specific gender/age subgroup under study (Peppard et al.,
2013).
SDB has been shown to cause disrupted sleep patterns, intermittent hypoxia,
abnormal heart rhythms, hypertension, and increased intrathoracic pressure (Somers et
al., 2008). Population based studies have illustrated an association between SDB and
cardiovascular disease (Shahar et al., 2001); metabolic syndrome (Kawada, Otsuka,
Nakamura, & Kon, 2015); hypertension (Geiger & Shankar, 2015); cognitive function
(Addison-Brown et al., 2014; Blackwell et al., 2015); liver disease (Trzepizur et al.,
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2016); kidney disease (Molnar et al., 2015); quality of life; genetic mutations, specifically
apolipoprotein epsilon 4 (Gottlieb et al., 2004); and mortality (Gami et al., 2013).
There is a gap in the knowledge about the association between AMD and SDB.
Currently, Retina Specialists and Ear Nose and Throat (ENT) Specialists do not routinely
co-manage patients. Recently, there has been an increased interest in understanding the
association between these two chronic diseases. A statistically significant association
(OR=3.3; 95% CI 1.32-8.27) between short sleep duration and neovascular AMD (PerezCanales, Rico-Sergado, & Perez-Santonja, 2016). Similar findings have been shown with
OSA and AMD (Keenan, Goldacre, & Goldacre, 2016). Sleep duration may also be
associated with geographic atrophy (Khurana et al., 2016).
The current study has potential implications for positive social change. The
resulting data may provide health care providers and patients a better understanding of
how to better manage both AMD and SDB from a multi-disciplinary approach and could
support the creation of public health interventions to improve screening, prevention
and/or treatment of SDB, ultimately resulting in better AMD outcomes. Patients and
physicians do not currently see vision loss as a consequence of SDB. But fear of vision
loss could increase patients’ impetus for getting screened for SDB, improving compliance
with therapies, such as continuous positive airway pressure (CPAP), and adding to the
cost-effectiveness argument with payers for covering screening and prevention. A more
detailed discussion of the data on AMD and SDB is provided in Chapter 2.
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Problem Statement
Age-related eye disease is a growing public health problem throughout the world
(Pascolini & Mariotti, 2012) The human retina requires a significant amount of energy
to keep its photoreceptors at an optimum functioning state and when oxygen is removed a
significant increase in lactate ensues (Ames, Li, Heher, & Kimble, 1992). Based on this
high-energy demand, nature has given it the greatest blood flow of any organ in the body
relative to its size (Blasiak, Petrovski, Vereb, Facsko, & Kaarniranta, 2014; Boltz et al.,
2010; Remsch, Spraul, Lang, & Lang, 2000). This places the retina in a precarious state
when oxygen levels in the blood drop. Chronic apnea/hypopnea episodes during SDB can
lead to damage from ischemia and hypoxia. In some cases, chronic apnea/hypopnea
episodes may lead to pathological changes and/or irreversible damage to the retina
(Blasiak et al., 2014).
SDB is shown to be commonly underdiagnosed or misdiagnosed, and
subsequently untreated (Gibson, 2004; T. Young, Evans, Finn, & Palta, 1997). SDB can
be treated effectively with CPAP, although many patients are poorly compliant with the
therapy (Weaver & Grunstein, 2008). Based on the combination of underdiagnosis,misdiagnosis, and poor compliance, a significant portion of patients experience regular
apneas and hypopneas during sleep (Peppard et al., 2013). Researching the possible
association between AMD and SDB addresses a current gap in the literature; research
could lead to additional understanding and thus promote awareness, screening, and
improved adherence to preventive therapy.
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Purpose of the Study
The purpose of this quantitative, cross-sectional study was to evaluate the
association between SDB and AMD in noninstitutionalized U.S. adults using the 2005–
2008 NHANES dataset. Based on nationally representative data, I investigated whether
respondents with SDB (independent variable) had an increased prevalence of AMD
(dependent variable). The intent of the study was to address the gap in understanding
whether SDB is associated with the development of AMD and to add to the current
literature on the association between the two diseases. using data from the 2005–2008
NHANES retinal fundus photograph evaluation and sleep disorder questionnaire (CDC,
2016a). I selected this dataset due to the availability of AMD data based on masked
central grading of retinal fundus photographs unique to this NHANES sampling period.
Research Questions and Hypothesis
The research questions and associated hypotheses that will guide this study are as
follows:
Research Question 1: Is there an association between self-reported SDB and
fundus photography identified AMD among adults 40 years and older who
participated in the 2005–2008 NHANES survey before and after
controlling for age, smoking, and BMI?
H01: There is no association between self-reported SDB and fundus
photography identified AMD among adults 40 years and older who
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participated in the 2005–2008 NHANES survey before and after
controlling for age, smoking, and BMI.
H11: There is an association between self-reported SDB and fundus
photography identified AMD among adult 40 years and older who
participated in the 2005–2008 NHANES survey before and after
controlling for age, smoking, and BMI.
Research Question 2: Is there an association between self-reported SDB and
fundus photography identified neovascular AMD among adults 40 years
and older who participated in the 2005–2008 NHANES survey before and
after controlling for age, smoking, and BMI?
H02: There is no association between self-reported SDB and fundus
photography identified neovascular AMD among adults 40 years and
older who participated in the 2005–2008 NHANES survey before and
after controlling for age, smoking, and BMI.
H12: There is an association between self-reported SDB and fundus
photography identified neovascular AMD among adult 40 years and
older who participated in the 2005–2008NHANES survey before and
after controlling for age, smoking, and BMI.
Research Question 3: Is there an association between self-reported SDB and
fundus photography identified geographic atrophy among adults 40 years
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and older who participated in the 2005–2008 NHANES survey before and
after controlling for age, smoking, and BMI?
H03: There is no association between self-reported SDB and fundus
photography identified geographic atrophy among adults 40 years and
older who participated in the 2005–2008 NHANES survey.
H13: There is an association between self-reported SDB and fundus
photography identified geographic atrophy among adult 40 years and
older who participated in the 2005–2008 NHANES survey.
Theoretical Framework
Life course theory, or the life course approach, is based on an interdisciplinary
framework for guiding research on health, human development, and aging (D. Kuh, BenShlomo, Lynch, Hallqvist, & Power, 2003). The approach is applicable to chronic
disease, infectious disease, and a number of other areas of public health (Ben-Shlomo &
Kuh, 2002; D. Kuh et al., 2003; Lynch & Smith, 2005). The theory can help explain how
biological, behavioral, environmental, and psychosocial processes that operate across an
individual’s life course, or across generations, may influence the development of disease
risk (D. Kuh et al., 2003). The time factor for the development of AMD is important
within the context of this framework. AMD has a predictably long latency period and
exposures—for example, recurrent hypoxic episodes during SDB which are likely to
occur earlier in life—may promote late disease progression (Lynch & Smith, 2005).
Although the study collected data on SDB from a single point in time due to the cross-
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sectional design, it is likely that the SDB data represent an ongoing condition. Evidence
from the literature on the development of AMD implicated a number of risk factors: age,
smoking (Myers et al., 2014; Thornton et al., 2005; Velilla et al., 2013), race and/or
ethnicity (Klein, Li, et al., 2013; W. Wong et al., 2014), family history (Seddon, Cote, et
al., 2005), obesity (Clemons et al., 2005), and a number of genetic mutations (Kanda et
al., 2007; Klein, Myers, et al., 2013; Seddon et al., 2007; Triebwasser et al., 2015; van
Lookeren Campagne et al., 2014). As previously stated, genetic studies have shown that
inheritable mutations may account for up to 70% of the risk for AMD (Seddon, Cote, et
al., 2005; van Lookeren Campagne et al., 2014). The mutations, present from birth, may
represent the first “hit” that occurs with the life-course progression of AMD. Although
the genetic associations are strong for AMD, the penetrance of the disease varies with
some individuals who present with mild signs of disease, such as drusen, a yellowish
deposit under the retina, alone, others with the non-neovascular form of AMD, and
finally 10% of patients progressing to severe AMD, including choroidal
neovascularization and geographic atrophy (Friedman et al., 2004; Klein et al., 2011).
This evidence suggests that additional factor(s) can influence AMD patients in addition to
their genetic predisposition and thus cause their disease to progress later in life. These
represent additional hits that may increase the risk of developing AMD. Figure 1
illustrates a life course theory model applied to the study of AMD pathogenesis and
incorporating the hypothesis of a potential association with SDB.
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Figure 1. Life course theory model of AMD pathogenesis incorporating the hypothesis of
a potential association with SDB.

A number of the criteria for causation proposed by Bradford Hill (1965) are
relevant to AMD and SDB. As discussed, there is biological plausibility that ischemia
and hypoxia play a role in AMD (Blasiak et al., 2014; Grunwald, Metelitsina, Dupont,
Ying, & Maguire, 2005). Coherence exists in that the cause-and-effect association of
ischemia and hypoxia with the disease fit the natural history of the disease (Grunwald et
al., 2005). There is a temporal relationship between the peak presentation of SDB and the
presentation of signs associated with early AMD (Bixler, Vgontzas, Ten Have, Tyson, &
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Kales, 1998; Bourne et al., 2014). This study and its inherent research questions
attempted to add to the data related to causality by providing evidence of consistency,
strength of association, and biological gradient. A more detailed discussion of the life
course theory of chronic disease is presented in Chapter 2.
One other conceptual model, the chronic care model (CCM), was assessed for this
study (Wagner et al., 2001). The CCM was initially developed by Wagner et al. in 1996
and its’ aim was to “transform the daily care for patients with chronic illnesses from
acute and reactive to proactive, planned, and population-based” (Wagner, Austin, & Von
Korff, 1996, p. 13). The CCM addresses the shortcomings of the current delivery of care
to chronic diseases, as they are often managed much the same way as an acute condition.
This model does not integrate well with the research question of this study as it does not
take into account the events over the course of the patients’ lifetime that may have
contributed to disease. For this reason, the life course theory was chosen as the theoretical
framework for this study.
Nature of the Study
In this study, I used a quantitative, cross-sectional approach to understand
whether SDB characteristics are associated with early or late AMD. Quantitative data are
most appropriate to investigate this association with appropriate inferential testing. Data
from the 2005–2008 NHANES retinal fundus photograph evaluation, and sleep disorder
questionnaire were used in this analysis (CDC, 2016a). Because the NHANES survey is
a national survey that includes a representative sampling of the U.S. population, with
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oversampling of certain underrepresented groups (including the elderly as it pertains to
this study), the data will enable extrapolation to the U.S. population (CDC, 2011). The
surveys from the years 2005-2006 and 2007-2008 contain data from a retinal fundus
photograph evaluation (choroidal neovascularization, geographic atrophy, AMD
severity), and sleep disorder questionnaire (SDB severity based on questions about sleep
apnea, insomnia, short sleep duration, and other sleep disturbances). Retinal fundus
photography from these sampling frames was graded by masked graders at the Wisconsin
Epidemiological Grading Center (CDC, 2005). This combination of survey and
examination methodology was appropriate for answering this research question because it
allowed me to use data from the U.S. population that included individuals who may have
AMD but are unaware and/or undiagnosed. Grading of fundus photographs by a central
reading center reduces misclassification bias by categorizing participants based on
photography findings and not relying upon participant recall. Participants who were not
aware, or had not been formally diagnosed with AMD, were identified by trained
independent graders (CDC, 2005).
To answer the research questions, I conducted a chi-square test for association to
determine any differences in the distribution of AMD across sociodemographic, lifestyle,
and sleep characteristics. Cumulative odds ordinal logistic regression (OLR) with
proportional odds (ordinal dependent variable with responses no AMD, early AMD, late
AMD) regression and binomial logistic regression modeling (dependent variable with
responses no choroidal neovascularization, choroidal neovascularization present; no
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geographic atrophy, geographic atrophy present) were fit to understand the association
between AMD and sleep parameters after adjustment for sociodemographic and lifestyle
factors. Survey specific sampling design variables and sampling weights were
incorporated in the analyses to account for the complex multistage sampling design of
NHANES. Definitions for early and late AMD with the 2005–2008 dataset have been
previously defined (Klein et al., 1991) and operationalized from this same dataset looking
at AMD prevalence (Klein et al., 2011). OLR allowed me to use the robust data provided
from the masked reading of fundus images. Logistic regression was performed to
determine whether the presence of AMD could be predicted by self-reported SDB,
categorized by the definitions of Chen, Redline, Shields, Williams, & Williams (2014).
Additional covariates were included in the model: age, race/ethnicity, smoking history,
body mass index (BMI), and diabetes status. ORs with 95% confidence intervals are
reported.
Definition of Terms
AMD): A degenerative disease of the retina that primarily impacts the macular
region and is currently the leading cause of blindness in industrialized countries (NEI,
2016b; WHO, 2015)
Choroidal neovascularization: Often termed neovascular AMD (nAMD) or wet
AMD, choroidal neovascularization is the formation of new and/or abnormal blood
vessels from the choroid layer of the retina. In choroidal neovascularization, the vessels
grow underneath the macula region of the retina, which under normal conditions is
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avascular. These vessels, due to their immaturity, leak fluid, lipid, and proteins into the
surrounding tissues. Ultimately, this process results in scar formation in the central
portion of the retina that negatively impacts vision (NEI, 2016b).
Continuous Positive Airway Pressure: A mechanical ventilation device that is
placed over the nose and/or mouth during sleep to provide positive airway pressure that
opens the area of obstruction and allows for improved oxygen saturation. Although
highly effective, most subjects are non-compliant with the treatment modality (Weaver &
Grunstein, 2008).
Drusen: Drusen are yellowish deposits under the retina that are present and can be
seen in early AMD. Components of drusen include lipid, inflammatory proteins, and
photoreceptor breakdown products (Mullins, Russell, Anderson, & Hageman, 2000).
Geographic Atrophy: Defined as the late stage of dry AMD. Geographic atrophy
consists of areas of retina devoid of the retinal pigment epithelial layer with subsequent
loss of the overlying photoreceptor layer (NEI, 2016).
OSA: A condition that occurs during sleep where a subjects tongue falls back
against his or her soft palate, causing the soft palate and uvula fall back against the back
of the throat, mechanically closing the airway (American Sleep Apnea Association,
2016).
Polysomnography : Also commonly called a sleep study, is a clinical procedure
that records brain activity, the oxygen level of the blood, heart rate and breathing, and
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documents eye and leg movements during the overnight study (Weaver & Grunstein,
2008)
SDB: Refers to a number of conditions that impact the overall quality of sleep for
an individual that include but are not limited to a formal diagnosis of sleep apnea. In the
context of the 2005–2008 NHANES data, this includes patient reported sleep apnea;
sleep apnea symptoms such as habitual snoring, snorting, or stopping breathing;
insomnia; short sleep duration; and any sleep disorder diagnosed by a physician or other
health professional (Chen et al., 2014).
Assumptions
The 2005–2008 NHANES dataset was used for this study. I assumed that the
sample I analyzed was representative of noninstitutionalized adults over 40 years in the
United States. In addition, I assumed that the NHANES Digital Grading Protocol for
evaluating fundus photographs was followed (CDC, 2005). Similar grading and staging
systems for AMD have been shown to have high reliability compared to standard clinical
examination (Bird et al., 1995; Seddon, Sharma, & Adelman, 2006). Masked grading of
the retina fundus images was important to this study in order to provide reliable
categorization of AMD status.
Scope and Delimitations
The 2005–2008 NHANES dataset was chosen for this study because it
represented a unique cross-sectional dataset with masked grading of fundus photography
for retinal disease. While SDB was based on participants’ self-report of disease, masked
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grading of AMD severity removed this need and minimized recall and/or report bias. In
addition, the severity grading of AMD allowed for additional information about the
disease to be incorporated into the analyses. A simple dichotomous answer from patient
self-report as to whether disease is present or absent would limit the amount of
information available for analyses and potentially introduce additional recall bias.
The NHANES dataset is a purposive sample from which an approximation of the
U.S. population was developed. This study was delimited to the population of the United
States in which the NHANES dataset was collected. Thus, the results are valid and
generalizable to the U.S. population where the survey was conducted. The results may
not be generalized to other non-U.S. populations. NHANES used oversampling to
improve the precision of estimates of health status indicators for population subgroups of
particular public health interest (Johnson et al., 2013). In 2005–2006, people aged 70 and
over were oversampled, while in 2007–2008 people aged 80 and over were oversampled
(Johnson et al., 2013). As AMD prevalence increased significantly with increasing age,
additional sampling of any subjects over the age of 40 will improve the precision of
estimating AMD prevalence in those subgroups (W. Wong et al., 2014).
Limitations
This study was subject to several limitations. First, given my use of crosssectional data I could not make a causal inference as to whether SDB leads to the
development of late or early AMD. Based on the limitations of the study design, this
study could only elucidate a better understanding of the association between these two
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conditions. It is possible that my findings could be explained by an underlying
mechanism that affects both AMD and SDB—there are a number of shared confounders
that include age, gender, obesity, diabetes status, and past and current smoking status (see
Chapter 2). Future research should be aimed at understanding and elucidating whether
SDB can cause AMD.
Second, SDB variables were assessed by self-reported questionnaire and thus
were subject to measurement and/or report bias. At the same time, however, multiple
questions surrounding SDB could also be a strength in that the variables collected in the
NHANES sleep questionnaire represented a wide range of questions on the topic of SDB.
Important information collected using the questionnaire might be lost if there were only
information on the absence/presence of SDB as diagnosed by polysomnography.
Third, there are inherent limitations to the NHANES sampling methodology
(CDC, 2011). The main limitation is that the survey incorporates only
noninstitutionalized U.S. citizens. As AMD presents primarily in the elderly population, a
significant number of potential participants could have been in nursing homes, hospitals,
and long-term care facilities (Klein et al., 2011). In addition, a small number of
participants opted out of, or were excluded from, undergoing digital fundus photography.
Also excluded were participants having no light perception, severe visual impairment in
both eyes, or an infection in at least one eye (CDC, 2005). Finally, the NHANES survey
data might not contain a representative sample of certain underrepresented age and/or
ethnic groups (Johnson et al., 2013).
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Fourth, a number of biases are inherent in survey research (Choi & Pak, 2005).
Nonresponse bias is a possibility in surveys such as NHANES as answers of participants
may differ from the potential answers of those participants who did not answer. There is
variability in the number of participants completing each specific questionnaire
(demographics, diabetes, sleep, etc.). Survey research such as the NHANES is subject to
recall bias from self-reported health outcomes that can ultimately result in subsequent
misclassification bias (Szklo & Nieto, 2014). The NHANES survey has been compared to
other surveys (Behavioral Risk Factor Surveillance System, National Health Interview
Survey, and National Survey on Drug Use) using self-reported public health data and is
found to have comparable predictive validity with these instruments (Li et al., 2012;
Pierannunzi, Hu, & Balluz, 2013). Additionally, the dependent variable in these analyses
was obtained from centralized masked grading of fundus photographs, which eliminates
this bias.
Significance
In this study, I examined whether insufficient sleep or sleep disturbances (SDB)
are associated with AMD using a sample of the U.S. population. U.S. Census Bureau
projections have estimated that the number of Americans over 65 years of age will more
than double to 87 million by the middle of this century (United States Census Bureau,
2015b). Thus, the number of persons with AMD is estimated to double by 2050, from
2.07 to 5.44 million patients (NEI, 2015). The public health impact of AMD is
significant, not only due to the increase in population blindness, but to the number of
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physical and mental comorbidities associated with visual impairment (Court, McLean,
Guthrie, Mercer, & Smith, 2014).
The results from this study are expected to add to the current body of literature on
the association between SDB and AMD. This additional understanding may have
important public health implications for promoting improved screening and treatment of
SDB in order to reduce the impact of AMD on the health of those older than 40 years. In
addition, an improved preventative treatment for AMD would decrease its costs in the
healthcare system. CPAP therapy has been shown to be effective in reducing morbidity
and mortality, although patients are highly noncompliant (Weaver & Grunstein, 2008). In
a poll conducted by Research!America and the Alliance for Eye and Vision Research
(AEVR), the fear of blindness was one of the top four "worst things that could happen to
you" for all respondents, including cancer, Alzheimer’s disease, and Human
Immunodeficiency Virus/Acquired Immune Deficiency Syndrome () (Association for
Research and Vision in Ophthalmology, 2014). The fear of blindness can be harnessed
during discussions between providers and patients; the fear of losing vision may promote
compliance with CPAP therapy. Conversely, for those patients who present with signs of
AMD, the retina specialist may provide referral to a sleep clinic for SDB diagnosis. Early
diagnosis and initiation of therapy for SDB could address not only the comorbidities
associated with SDB, but they could also prevent or slow the progression of AMD. This,
in turn, would lower the rates of vision loss, reduce comorbidities associated with vision

21
loss, and reduce the impact of AMD on the health care system and on the overall cost to
society.
Summary
AMD represents a serious global public health problem. With an aging population
and increasing life expectancy, AMD is expected to have a greater public health impact
in the future. Although in recent years, data has emerged that elucidate a strong genetic
association with AMD, the incomplete penetrance of the disease suggests that underlying
mechanisms are still poorly understood. SDB represents a potentially important variable
in the pathway of AMD pathogenesis (Figure 1).
In this chapter, I discussed the epidemiology of AMD and SDB, presented a brief
overview of the extant literature on these conditions and their potential relationship. I
presented the problems associated with an aging population and the consequences of
AMD and suggested this research is needed to further explore SDB as a risk factor for
this condition. I specified the research questions related to this research and the
quantitative methodology I used to address them. I also justified the use of the life course
theory as a framework for this research. An overview of the assumptions, scope and
limitations, including those based on the use of secondary data, of the study was
provided. Lastly, I concluded with a discussion on the significance of the current study
and implications for positive social change.
A detailed review of the literature on AMD and SDB is presented in Chapter 2. In
Chapter 3 I describe the research methodology, including the dependent, independent,
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and confounding variables, and the statistical testing was used to answer the research
questions. The results of this study are reported in Chapter 4; the summary, discussion,
and conclusions are presented in Chapter 5.
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Chapter 2: Literature Review
Introduction
The purpose of this quantitative, cross-sectional study was to evaluate the
association between SDB and AMD in noninstitutionalized U.S. adults based on
NHANES 2005-2008. Findings from this study will add to the current understanding of
the associations between these two chronic diseases.
The association between AMD and SDB is not well understood. (Keenan et al.,
2016; Perez-Canales et al., 2016) suggest that there is an association; Khurana et al.
(2016) does not. Khurana et al. (2016) have also shown an association between SDB
and late AMD (geographic atrophy) alone.
AMD is the third leading cause of blindness globally behind cataracts and
glaucoma; it is the leading cause of blindness in developed countries (WHO, 2015).
Because AMD is a disease that presents later in life, the elderly population is
disproportionately affected (WHO, 2015). The United Nations (UN) (2015) estimates that
globally, the population over 60 years of age is the fastest growing and is expected to
increase by 45% by the middle of the century. Thus, in the United States, the U.S.
Census Bureau projects that 1 in 5 Americans will be over the age of 65 by 2050 (United
States Census Bureau, 2015b). Given that AMD is age related, it is likely that as the
population grows older AMD will become a major public health problem. Wong et al.
(2014) performed a systematic review and meta-analysis of all population-based studies
[on what exactly?] that used retinal photographs and standardized grading classifications
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to determine the presence of disease. By their estimation, AMD is prevalent in
approximately 9% of the global population, which suggests that 196 million people will
have AMD by the year 2020 (W. Wong et al., 2014). The cause(s) of AMD remain
elusive. Data suggest a strong genetic association as well as a number of risk factors ,
including age, smoking (Myers et al., 2014; Thornton et al., 2005; Velilla et al., 2013),
race and/or ethnicity (Klein, Li, et al., 2013; W. Wong et al., 2014), family history
(Seddon, Cote, et al., 2005), obesity (Clemons et al., 2005), and a number of genetic
mutations (Kanda et al., 2007; Klein, Myers, et al., 2013; Seddon et al., 2007;
Triebwasser et al., 2015; van Lookeren Campagne et al., 2014). Despite a significant
amount of data supporting risk factors, the cause of AMD remains elusive. SDB causality
on the other hand is characterized with a higher degree of certainty.
SDB is defined as a number conditions, including central sleep apnea (CSA),
OSA, and sleep-related hypoventilation or hypoxemic syndromes (American Academy of
Sleep Medicine, 2014). During breathing-impaired sleep, the retina does not receive
appropriate oxygenation and nutrition, and thus is at risk for chronic and irreversible
damage. There is mounting evidence that SDB may be associated with AMD
pathogenesis and with retinal disorders in general (Barak, Sherman, & Schaal, 2012;
Boland et al., 2004; Boltz et al., 2010; Huseyinoglu et al., 2014; Perez-Canales et al.,
2016)This literature review covers the epidemiology of AMD and SDB, the risk factors
for each disease, the impact of SDB on the treatment of AMD, and finally the association
between AMD and SDB. There is also a review of the literature on the association
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between the two diseases and their relationship to the systemic and retinal vascular
system.
Literature Search Strategy
PubMed and Google Scholar were used to identify cohort or cross-sectional
studies that investigated the possibility of an association between AMD and SDB The
following Medical Subject Heading (MeSH) terms were used: age-related macular
degeneration, macular degeneration, choroidal neovascularization, GA, SBD, OSA, and
sleep apnea. The searches yielded more than 15,000 articles on these two chronic
diseases. To whittle down this number, the peer-reviewed articles were selected only if
(a) they were published after 1993, in English and in full text, and only if (b) the subjects
were over the age of 18 or they used the measure of Apnea-Hypopnea Index (AHI),
Respiratory Disturbance Index (RDI), self-reported physician diagnoses, or self-reported
sleep duration were included in the review. This narrowed down the total to about 300
articles.

.
Theoretical Foundation
The WHO has adopted the life course approach as one of its overarching
principles in the Global Action Plan for the Prevention and Control of Noncommunicable
Diseases (WHO, 2013). The life course theoretical model is based on an interdisciplinary
framework for guiding research on health, human development and aging (Diana Kuh &
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Ben-Shlomo, 2004). The origin of this theory can be traced back to research investigating
the impact of the Great Depression of the 1930s on individual and family pathways
(Elder, 1974). Elder (1974) used data from longitudinal studies to investigate the impact
of this time period on the long-term development of children born in the 1920s. As Kuh
et al. (2004) stated, the life course approach to epidemiology is more than the mere
collection of longitudinal data for analysis or associated with a particular research
methodology. Important components of the theoretical model are the temporal
relationships of the exposures and the relationships between these exposures. A challenge
that is often faced by practitioners of life-course epidemiology is how to translate the
findings into public health interventions as the biological, social and/or environmental
exposures have happened in the past. There are three main life-course models: the
cumulative exposure model, the chains of risk model, and the critical period model
(Diana Kuh & Ben-Shlomo, 2004). The models are not necessarily discreet and it is
possible that they may exist simultaneously or as slight variations with aspects of
multiple models (D. Kuh et al., 2003). The critical period model (Figure 2a) is based on
the premise that exposure(s) acting during a specific period (in utero for example) can
impart lifelong effects on the structure and/or function of organs and tissues in the body
(Nishi et al., 2015). These exposures can exert effects independently or in concert with
other exposures (Figure 2a). The chains of risk model (Figure 2b) posits that a sequence
of linked exposures act in a way such that a harmful exposure results in an exposure to a
subsequent harmful event, thus increasing risk (Nishi et al., 2015). The cumulative risk
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model is based on the accumulation of a number of types of risks that lead to long-term
damage and disease development (Nishi et al., 2015). This model differs from the chains
of risk model in that the exposures can work independently from one another. The
cumulative risk model (Figure 2c) was proposed as the most appropriate to explain the
relationship with SDB and AMD.

Figure 2. Life course causal models. Adapted with permission (Appendix A) from A Life
Course Approach to Chronic Disease Epidemiology (Page 10), by D. Kuh, 2004, New
York: Oxford University Press. Copyright 2004 by the Oxford University Press.
A cumulative risk model of AMD is illustrated in Figure 3.
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Figure 3. Life Course Cumulative Risk Model for AMD with SDB as a potential
exposure.
Time is an integral component of life course theory and is an undercurrent
exposure in the cumulative risk model of AMD. Age-related changes in the eye are not
specifically called out as a discrete exposure, but should be considered an exposure that
continually exists in the background of the model. Numerous studies have shown that
increasing age is associated with increasing risk of disease (Tomany et al., 2004). There
are several temporally associated exposures that have been shown to highly related to the
development of AMD. AMD has been associated with a number of genetic mutations,
most specifically with the genes that code for CFH and the ARMS2/HTRA1 gene (Kanda
et al., 2007; Seddon et al., 2007). The CFH gene has been shown to regulate the
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Complement system and keep Complement mediated inflammation under control (Zipfel,
Lauer, & Skerka, 2010). Mutation of the gene removes the protective effect and increases
inflammatory response in the retina. Both CFH and ARMS2/HTRA1 mutations have
been shown to be associated with drusen formation and progression of AMD (Dietzel et
al., 2014). These early exposures present at births represent the first in a series of
potential exposures as shown in Figure 3.
Although the reduction in smoking is one of the most successful Public Health
victories in the United States, exposure in early adult life and continued smoking for the
current >40 age group is still significant (Holford, Levy, & Meza, 2016). It has been
shown that compared to nonsmokers, past and current smokers develop late stage AMD a
mean of 4.9 and 7.7 years sooner, respectively (p < 0.001 for both) (Lechanteur et al.,
2015). When risk alleles for CFH and ARMS2/HTRA1 mutations and smoking are taken
into account, late stage AMD develops 12.2 years sooner, on average, then those with no
risk alleles (p < 0.001) (Lechanteur et al., 2015).
SDB represents a third, and potentially important exposure that may add to the
cumulative risk of developing AMD with hypoxia placing additional oxidative stress on
the already exposed retina (Barak et al., 2012; Keenan et al., 2016; Khurana et al., 2016;
Perez-Canales et al., 2016). Blasiak et al. (2014) have implicated hypoxia and oxidative
stress as important factors in the pathogenesis of AMD. Although the authors did not
speculate on the specific causes of hypoxia, their opinion was that anything that can
impair the blood supply to the retina might lead to hypoxia, oxidative stress, and cellular
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dysfunction. Chronic hypoxic episodes due to SDB could be a potential initiator of this
cascade.
AMD
AMD is a degenerative retinal disease primarily affecting the photoreceptor and
retinal pigment epithelium tissue layers leading to a progressive loss of vision. Early
AMD presents as lipid rich deposits called drusen and/or mild pigmentary changes in the
retina, normally without corresponding vision loss (Lim, Mitchell, Seddon, Holz, &
Wong, 2012). Vision loss from AMD usually is caused by one of two progressive
degenerative processes termed choroidal neovascularization (wet AMD); neovascular
AMD (nAMD) or geographic atrophy (dry AMD). Choroidal neovascularization
constitutes abnormal blood vessel formation in the sub-retinal pigment epithelial and
subretinal spaces (Lim et al., 2012). This form of AMD can cause dramatic reductions in
visual acuity due to exudation, pigment epithelial layer detachment (PED), retina pigment
epithelium tears, and ultimately leads to scarring of the retina (van Lookeren Campagne
et al., 2014; Yonekawa, Miller, & Kim, 2015). Geographical atrophy is characterized by
loss of the choriocapillaris layer of the retina and subsequent atrophy of the overlying
retinal pigment epithelial layer (Lim et al., 2012). This loss of critical tissue layers that
keep rods and cones healthy and functioning causes photoreceptor loss and subsequent
decline in visual acuity. Although this process is generally results in more gradual visual
acuity loss as compared to an acute decline with choroidal neovascularization, both
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processes can be equally detrimental to quality of life and independence for patients
(Coleman et al., 2010).
Patients with nAMD usually present to general ophthalmologists in their late 60s
or 70s, with a complaint of varying degrees of vision loss and/or metamorphopsia (Klein
et al., 2011; Ryan, 2013). The defining feature of nAMD is the presence choroidal
neovascularization, primarily diagnosed based on fluorescein angiography (Lim et al.,
2012). Choroidal neovascularization is the presence of a new blood vessel that originates
in the choroidal circulation of the retina and can be found underlying or penetrating
Bruchs membrane, violating the structural integrity of the blood retina barrier. This new
vessel emerges within the normally avascular macula region and due to its immature
morphology leaks serous and/or blood exudates into the surrounding retina tissue (Ryan,
2013; van Lookeren Campagne et al., 2014; Yonekawa et al., 2015). The end product of
this disease process is fibrous scarring of the retina and irreversible vision loss (Lim et
al., 2012). Subjects can be affected unilaterally or bilaterally (NEI, 2016b). Having
choroidal neovascularization in one eye predicts a higher risk for development of
choroidal neovascularization in the fellow eye (Silva et al., 2011). Current therapy for
nAMD consists of regular intraocular injections of anti-VEGF medications (Lim et al.,
2012). At the present time there are no preventive therapies available for nAMD.
Dry AMD is progressive disease with less acute symptom onset when compared
to nAMD and is a significant cause of moderate and severe loss of central vision in the
elderly population (Lim et al., 2012; Ryan, 2013). The disease is diagnosed based on a
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dilated fundus examination and diagnostic imaging including fundus photography, fundus
autofluorescence, and optical coherence tomography (OCT). Dry AMD is characterized
by the presence of drusen (yellowish deposits that develop within the macula) located
under the retinal pigment epithelial layer that can be visualized during examination and
documented based on fundus photography and OCT (Ryan, 2013). In dry AMD, thinning
of the retinal pigment epithelial layer in the macula develops, along with other agerelated changes to the adjacent retinal tissue layers. When severe, the late stage of dry
AMD is associated with thinning and loss of function of the neural retinal located above
the affected retinal pigment epithelial layer (Ryan, 2013). This collective phenotype in
late stage dry AMD is termed geographic atrophy. The progressive degeneration of lightsensitive photoreceptor cells in geographic atrophy leads to severe visual loss in affected
eyes. In addition, dry AMD can progress to the nAMD form of the disease (Holz, Strauss,
Schmitz-Valckenberg, & van Lookeren Campagne, 2014). Dry AMD is the most
common form of the disease, occurring in 85%-90% of AMD cases (Klein, Peto, Bird, &
Vannewkirk, 2004). Currently, no approved therapy exists for non-neovascular AMD.
The Age-Related Eye Disease Study (AREDS) has shown that taking lutein and
zeaxanthine supplements (and eating those foods rich in these nutrients such as spinach
and collard greens) is associated with a decreased risk of AMD and late stage AMD,
which includes choroidal neovascularization and geographic atrophy (Age-Related Eye
Disease Study 2 Research Group, 2013; SanGiovanni et al., 2008). The absence of
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treatment options for dry AMD represents an area of urgent unmet medical need, and a
major public health concern for the rapidly increasing elderly population.
Risk Factors for AMD
A number of population based cohort studies examined the relationship between
AMD and a variety of possible risk factors. In 1992, the Age-Related Eye Disease Study
(AREDS) Research Group enrolled participants with varying degrees of AMD severity in
a study to understand the clinical course and prognosis of AMD. Since then, a number of
epidemiological studies have provided insight into the complex interplay of genetic,
environmental, metabolic, and demographic factors that have been shown to be
associated with the development of AMD (E. Chew et al., 2014; Tomany et al., 2004). To
illustrate these risk factors, data from the ten-year follow up of the AREDS cohort (E.
Chew et al., 2014) as well as individual study data and pooled data from Tomany et al.
(2004) that includes data from the 3 largest population based cohort studies (resulting in a
pooled population of 9523 adults)- the Beaver Dam Eye Study (BDES, United States),
the Blue Mountain Eye Study (Australia), and the Rotterdam Study (RS, Netherlands)
will be used.
Age. Age is commonly accepted risk factor for AMD as the presentation of the
disease is uncommon before the fifth decade of life (Ryan, 2013). In the longitudinally
followed AREDS cohort, age was an identified factor that increased the risk of
developing late stage AMD over each 5-year period in the 65-69, 70-74, ≥75 age groups
by 33%, 53%, and 86%, respectively as compared to the 55-64 age group (E. Chew et al.,
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2014). In the Blue Mountain Eye Study, age was strongly correlated with both late and
early AMD (p<0.0001) (Joachim et al., 2015). Similar results were found in the BDES
and RS studies (Klein et al., 2007; Smith et al., 2001).
Genetics. Studies on concordance rates of AMD between monozygotic (MZ) and
dizygotic (DZ) twins have shown that rates are double in those twins that originate from
the same ovum (18% and 6% for MZ pairs and DZ twin pairs, respectively) (Seddon,
Cote, et al., 2005). Models predict that heritability may account for 46% to 71% of the
variability with AMD (Seddon, Cote, et al., 2005). AMD has also been shown to have a
strong association with a number of genetic mutations (Edwards et al., 2005; Hageman et
al., 2005; Haines et al., 2005; Jakobsdottir et al., 2005; Kanda et al., 2007; Klein, Myers,
et al., 2013; Ratnapriya & Chew, 2013; Seddon et al., 2007; van Lookeren Campagne et
al., 2014). AMD is most strongly associated with genes that code for CFH (Edwards et
al., 2005; Hageman et al., 2005; Haines et al., 2005) and the ARMS2/HTRA1 gene
(Kanda et al., 2007; Seddon et al., 2007). The human genome project has greatly added to
the understanding of this disease by allowing for the ability to perform genome wide
association studies (GWAS). A number of GWAS studies have independently confirmed
genetic variation at the same CFH (Edwards et al., 2005; Hageman et al., 2005; Haines et
al., 2005) and ARMS2/HTRA1 (Jakobsdottir et al., 2005; Rivera et al., 2005) coding
regions. In a French cohort, those subjects with the high risk CFH polymorphism (OR,
6.21) and those subjects with the high-risk ARMS2/HTRA1 (OR, 11.7) polymorphisms
were associated with significantly higher risks of developing nAMD (Zerbib et al., 2014).
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Smoking. In the early 1990’s researchers began to investigate the relationship
between smoking and eye disease; in particular the association of smoking and AMD
(Eye Disease Case-Control Study Group, 1992). In the pooled BDES, Blue Mountain Eye
Study, and RS population, past smokers and current smokers were 5.52 and 6.19 times
more likely to develop AMD compared to nonsmokers, respectively. In the AREDS
cohort, current smokers had a 56% higher risk of advanced AMD versus nonsmokers (E.
Chew et al., 2014).
Inflammation. There is evidence that both the wet and dry forms of AMD are
associated with an inflammatory process (Ambati & Fowler, 2012; van Lookeren
Campagne et al., 2014). Excessive activation of inflammatory and immune responses
within the retina, coupled with the retinal pigment epithelial and photoreceptor
degeneration, is thought to result in activation of cells that produce complement
components, pro-inflammatory cytokines, and growth factors resulting in increased
angiogenesis and vascular permeability (Ambati & Fowler, 2012). Patients with AMD
have been shown to elevate systemic inflammatory biomarkers such as c-reactive protein
(CRP), interleukin-6 (IL-6), and homocysteine (Seddon, George, Rosner, & Rifai, 2005).
Surgically excised choroidal neovascularization tissue in patients with nAMD has been
shown to contain a number of different types of inflammatory cells (Submacular Surgery
Trials Research Group, 2005). Dry AMD has been associated with activation of the
complement System (Reynolds et al., 2009; Whitmore et al., 2015). The complement
pathway is part of the body’s innate immune system that consists of a complex cascade of
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serum proteins that interact to mount a defense against foreign pathogens. The
complement cascade is activated via the classical (antibody-dependent), the alternative
(antibody independent) and the lectin pathways. Local inflammation and activation of the
complement cascade has been implicated in drusen formation, as the proteins of the
complement pathway have been shown histologically to be a component of drusen (Wang
et al., 2010). Furthermore, as stated previously, polymorphism in genes coding for
complement or complement regulatory proteins have demonstrated increased risk in the
development of AMD (Edwards et al., 2005; Haines et al., 2005; Klein, Myers, et al.,
2013; Triebwasser et al., 2015).
Ethnicity. There are wide variations in the prevalence estimation of AMD and
nAMD due to the heterogeneity of study populations and the use of different diagnostic
criteria. However, there is a strong evidence suggesting that the prevalence of AMD,
including nAMD, is much higher in the population of European ancestry than that in any
other ethnicity (W. Wong et al., 2014). In the AREDS study there was a 183% higher risk
of AMD in the Caucasian versus non-Caucasian populations (E. Chew et al., 2014).
Among people of European ancestry, the annual incidence of late AMD is estimated to
vary from 2.9 to 3.6 per 1,000 person-years (Buitendijk et al., 2013).
Sex. AMD is predominantly present in the female population (Klein et al., 2011).
In the AREDS study there was a 23% higher risk of AMD in women vs. men (E. Chew et
al., 2014). In the RS study, an increased number of years between menarche and
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menopause were associated with GA, suggesting that female sex hormones may play a
minor role in disease progression (Tomany et al., 2004).
Associated Disease. In a U.S. Medicare cohort, diagnosis of diabetic retinopathy
(DR) significantly increased the risk of nAMD (Hahn, Acquah, Cousins, Lee, & Sloan,
2013). Compared with non-diabetics, those with proliferative retinopathy were at a
considerably higher risk (115%) than those with non-proliferative (68%) DR. However,
having diabetes alone was not associated with an increased risk of developing nAMD.
Obesity has been weakly associated with a higher risk of developing nAMD (Zerbib et
al., 2014; Q. Zhang et al., 2016).
Classification and Severity Scale of AMD
Classification and severity scales for AMD have been developed based on
findings from clinical examination and diagnostic imaging using fundus photography,
fluorescein angiography, and optical coherence tomography (OCT). These scales range
from a categorization of no aging changes present in the retina to late AMD, which
includes choroidal neovascularization and geographic atrophy (Ferris et al., 2013;
Nivison-Smith, Milston, Madigan, & Kalloniatis, 2014). Nivison-Smith et al. (2014)
provide a detailed description of the Age-Related Eye Disease Study (AREDS)
classification scheme that identifies clinical signs and pigmentary changes within the
macula associated with progression of early AMD to late AMD. These grading scales are
often used in clinical trials and epidemiological studies where masked grading of images
are used to characterize the presence and/or extent of disease (Nivison-Smith et al.,
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2014). As this study will be using data from the masked grading of the 2005–2008
NHANES survey period, the classification proposed by Klein et al. (1991) and adopted
for the NHANES Digital Grading Protocol (CDC, 2005) to define early and late AMD
will be employed. This will be detailed further in Chapter 3 in the explanation of study
methodology section. The NHANES Digital Grading Protocol defined “early” AMD as
the presence of either soft drusen with a grid area of greater than a 500 μm circle and the
presence of retinal pigment epithelial depigmentation or increased retinal pigment or by
the presence of soft drusen within the center 125 μm circle with the presence of retinal
pigment epithelial depigmentation or increased retinal pigment in absence of signs of late
AMD. “Late” AMD was defined by the presence of any of late lesions, such as GA,
subretinal hemorrhage or visible subretinal new vessels, PED/retinal detachment,
subretinal fibrous scar or laser treatment scar, or self-reported history of photodynamic or
anti–vascular endothelial growth factor treatment for exudative AMD (Klein et al., 2011).
AMD Epidemiology
Globally, 8.7% of all cases of blindness are attributed to AMD (W. Wong et al.,
2014), a majority of which can be found in developed nations. The United Nations (UN)
reports that population ageing is taking place in nearly all countries throughout the world
resulting from decreasing mortality and declining fertility (United Nations, 2013). Similar
trends are seen in the United States as the Census Bureau suggested that the number of
Americans over 65 years of age will more than double to 87 million by the middle of this
century (United States Census Bureau, 2015a). AMD prevalence in the United States is
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estimated to double by 2050 from 2.07 to 5.44 million patients (NEI, 2016b). The global
prevalence of early, late, and any AMD were shown in a meta-analysis of populationbased studies to be to be 8.0%, 0.37%, and 8.7%, respectively (W. Wong et al., 2014). As
seen in other multi-ethnic studies, the highest prevalence of AMD was found in the
people of European ancestry at 0.50% followed by Asian and Hispanic ethnicities. The
AMD prevalence rate is lowest among people of African ancestry at 0.28% (W. Wong et
al., 2014).
Wong et al. (2014) estimated that by 2020, 11.26 million patients will be
diagnosed with late AMD, and the current prevalence of 9.64 million will nearly double
to 18.57 million within next 25 years. Due to global trends in population growth,
maximum prevalence increase will be seen in Asia, followed by Europe. In Asia, the
prevalence of late AMD is likely to increase from 4.59 million patients in 2014 to 9.92
million in 2040, whereas in Europe, the prevalence is projected to increase from 2.57
million to 3.69 million during the same time period (W. Wong et al., 2014).
There is some variation in the prevalence estimates of AMD and nAMD due to
the heterogeneity of study populations and the use of different diagnostic criteria. Klein et
al. (2011) reported that the overall prevalence of AMD in the 40 and older population of
the United States based on the NHANES survey was 6.5%. Late AMD (choroidal
neovascularization and geographic atrophy) was present in 0.8% of the population. The
disease varies by ethnicity, and was shown to be present 7.3%, 2.4%, and 5.1% of nonHispanic Whites, non-Hispanic Black, and Mexican Americans, respectively (Klein et al.,
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2011). As the NHANES survey draws from predominantly Caucasian respondents, the
prevalence numbers may not accurately represent other ethnic groups. In the Los Angeles
Latinos Eye Study (LALES) the adjusted prevalence of AMD was 10.2% with late AMD
present in 0.52% of the Latino population. The Multi-Ethnic Study of Atherosclerosis
(MESA) aimed to study the incidence of AMD and associated risk factors in White,
Black, Hispanic, and Chinese residents of the United States (Fisher et al., 2016). Subject
retinal photography data was collected 8 years apart to look for signs of early and late
AMD. The incidence of early and late AMD was 4.1% and 2.3%, respectively. Consistent
with other studies of AMD, incidence of early and late AMD was highest in Whites
(5.3% and 4.1%, respectively), followed by Chinese (4.5% and 2.2%, respectively),
Hispanics (3.3% and 0.8%, respectively), and lowest in Blacks (1.6% and 0.4%,
respectively) (Fisher et al., 2016).
SDB
SDB is defined by the American Academy of Sleep Medicine as a constellation of
conditions that includes central sleep apnea (CSA), OSA, and sleep-related
hypoventilation or hypoxemic syndromes (American Academy of Sleep Medicine, 2014).
During SDB patients experience periods of apnea (breathing cessation) and hypopnea
(periods of shallow breathing). The public health impact of SDB is significant, as the
disease has been implicated as a risk factor for a number of chronic diseases including
cardiovascular disease, obesity, diabetes, and depression (CDC, 2016b). Each of these
diseases is associated with a significant morbidity and mortality profile and responsible
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for much of the chronic disease burden in the United States (Bauer, Briss, Goodman, &
Bowman, 2014). Long-term consequences of SDB include reduced quality of life
(Batool-Anwar et al., 2016), cognitive impairment (Osorio et al., 2015), increased risk of
motor vehicle accidents (Basoglu & Tasbakan, 2014); cerebrovascular (Arzt, Young,
Finn, Skatrud, & Bradley, 2005), cardiovascular (Kendzerska, Gershon, Hawker, Leung,
& Tomlinson, 2014), and metabolic disease (Kawada et al., 2015); and increased
mortality (Kendzerska et al., 2014).
The gold standard for diagnosing and monitoring SDB and OSA is a
polysomnography (PSG) examination, otherwise known as a “sleep study” (Epstein et al.,
2009). During the sleep study, patients are monitored for events where there is cessation
of breathing or shallow breathing as well as changes in brain activity, blood oxygen level,
heart rate and eye/leg movements. This is most often done in a clinical setting over the
course of one or more nights by highly trained staff. Home sleep monitoring devices are
available, although reliability is poor compared to PSG and misclassification is possible
(Aurora, Swartz, & Punjabi, 2015).
Current front-line treatment for moderate to severe OSA and SDB is the use of
CPAP, a device that consists of an air pump connected to a hose/mask apparatus that is
fitted to the face of the patient with SDB (Epstein et al., 2009). Air is forced through the
hose/mask under positive pressure and forces open the upper airway, allowing for
improved oxygenation in the lungs. CPAP has been shown to be highly effective in
improving objective measures of SDB in a number of randomized clinical trials
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(McMillan et al., 2014; T. Young et al., 1993). The effects of CPAP therapy are not
limited to improving objective measures of SDB, but have been shown to improve
cognitive functioning (Aaronson et al., 2016), glucose metabolism (Pamidi et al., 2015;
Salord et al., 2016), cholesterol profile (McMillan et al., 2014), and cardiovascular
outcomes (Marin, Carrizo, Vicente, & Agusti, 2005). Unfortunately, CPAP has been also
found to be a notoriously non-compliant treatment modality (Weaver & Grunstein, 2008).
Participants in clinical trials with low compliance do not attain the same results seen in
those studies that utilize the device as prescribed. A number of recent trials have shown
that real world initiation of CPAP therapy does not reduce oxidative stress (as measured
by cardiovascular stress/inflammation biomarkers) or reduce long-term adverse
cardiovascular outcomes (Paz et al., 2016; Peker et al., 2016). Once the data are adjusted
for compliance to CPAP treatment, the reduction in inflammatory biomarkers from
therapy becomes significant (Paz et al., 2016).
There are other treatment options for the patient with SDB including mandibular
advancement devices (MAD) (oral appliances) that are worn in the mouth during sleep to
attempt to mechanically open the upper airway by pushing the jaw forward (D. Young &
Collop, 2014). Surgical interventions are available to patients with SDB, although they
are highly invasive as compared to MAD or CPAP. Surgical intervention remains a
second line treatment for moderate to severe OSA, even in light of the data illustrating
that uvulopalatopharyngoplasty (UPPP) and maxillomandibular advancement (MMA)
surgeries have shown statistically significant improvements in AHI (D. Young & Collop,
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2014). A number of other strategies should be employed to combat SDB including
diet/weight loss, increase in amount of exercise, and sleep posture regardless of
CPAP/MAD/surgical approaches. Weight loss (Peppard, Young, Palta, Dempsey, &
Skatrud, 2000) and increased exercise (Mendelson et al., 2016) have shown to improve
objective measures of SDB. To date pharmacotherapy for SDB has not proven to be an
effective treatment modality (Jordan, McSharry, & Malhotra, 2014).
Classification and Severity Scale of SDB
During the PSG examination, oxygen saturation of the blood is monitored.
Shallow breathing causing reductions in blood oxygen saturation are termed hypopneas.
Apnea is defined as a complete pause in breathing lasting at least 10 seconds during sleep
(Epstein et al., 2009). By counting the number apneas and hypopneas in an hour of sleep,
one can derive the apnea-hypopnea index (AHI), a categorical measure of OSA/SDB.
The AHI is categorized in most of the currently published studies according to the
following consensus cutoff points illustrated in Table 1 (Epstein et al., 2009).
Table 1
Apnea-Hypoapnea Index (AHI) Severity Categories for OSA
Category
AHI
Normal
0
Minimal OSA
> 0 to ≤ 5
Mild OSA
5 to ≤ 15
Moderate OSA
15 to ≤ 30
Severe OSA
≥ 30
Note: Adapted from Epstein et al. (2009)
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Risk Factors Associated with SBD
Anatomy. OSA syndrome is defined as a condition where there are repeated
episodes of complete or partial blockage of the upper airway during sleep (Jordan et al.,
2014). There are a number of anatomical factors that lead to a restricted airway
associated with OSA/SDB (Schwab et al., 2003). These include decreased size of the
airway lumen, enlarged tonsils, craniofacial anatomy abnormalities (retrognathia for
example), tongue volume, and body fat in the neck area surrounding the airway. These
anatomical changes contribute to airway collapse during sleep. A number of upper airway
muscles that are aroused during wakefulness and become relaxed during sleep have also
been implicated as a causative factor (Mezzanotte, Tangel, & White, 1992). Inflammation
of the upper airway due to environmental exposures such as smoking or chronic sinusitis
can also play a role in SDB (Peppard et al., 2013; T. Young, Peppard, & Gottlieb, 2002).
Obesity. Obesity is a major risk factor for SDB, a significant public health
concern as much of the United States population is considered overweight (Franklin,
Sahlin, Stenlund, & Lindberg, 2013; Heinzer et al., 2015; Peppard et al., 2013). A
number of studies have shown that weight loss, even in morbidly obese individuals
undergoing gastric bypass surgery can improve symptoms of SDB (Barvaux, Aubert, &
Rodenstein, 2000; Grunstein et al., 2007).
Age. SDB does not seem to be as prevalent in both young and elderly patients and
has been shown to peak in the 45-64 year-old age group (Bixler et al., 1998). This
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phenomenon of increasing prevalence of OSA with age and then a reduction in cases
after age 60 was found in both men and women in the Wisconsin Sleep Cohort Study (T.
Young et al., 1993). This phenomenon may be partially explained by unreliable results
from the smaller sample of elderly participants represented in the study population. Many
SDB studies choose working age populations as their sample, and therefore the elderly
population is under sampled. These results were not found in a study of women in
Sweden where participants were selected from the general population without bias for
selecting certain age categories. In this study OSA was found in 24% (95% CI: 45–55%)
of females aged 20–44 years, in 56% (95% CI: 47–65%) of females aged 45–54 years
and in 75% (95% CI: 67–82%) of females aged 55–70 years (Franklin et al., 2013).
Gender. SDB is generally two times more prevalent in men than in women (Ip,
Lam, et al., 2004; Kim et al., 2004; T. Young et al., 1993).
Smoking. Analysis of participants from the Wisconsin Sleep Cohort Study
indicate that compared with those that have never smoked, current smokers had a
significantly greater risk of moderate or worse SDB (OR, 4.44) (Wetter, Young, Bidwell,
Badr, & Palta, 1994). In a study of 964 patients that were former and current smokers
referred to an outpatient sleep clinic there was a statistically significant association with
younger age of onset and severity of OSA (Varol, Anar, Tuzel, Guclu, & Ucar, 2015).
Results to the contrary have been reported from a University Hospital sleep clinic study
of over 3,000 men (Hoflstein, 2002). In the study logistic regression revealed that heavy
smokers (>30 pack years) had approximately twice the risk of having AHI >50 compared
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to nonsmokers, although the OR was <1.0 after adjusting for age, BMI, and gender
(Hoflstein, 2002).
Alcohol. Alcohol use as a risk factor is inconclusive as it was studied as a variable
in a number of epidemiological studies and an association was noted in some, but not
found in others (Peppard, Austin, & Brown, 2007; Udwadia, Doshi, Lonkar, & Singh,
2004). In the Wisconsin Sleep Cohort study, men who consumed more alcohol had 25%
greater odds of mild or worse SDB (OR = 1.25, 95% CI: 1.07-1.46, p = 0.006). For
women, alcohol consumption was not significantly associated with increased risk of SDB
(Peppard et al., 2007).
The Association of SDB and CVD
SDB is associated with a number of cardiovascular and cerebrovascular diseases
(Arzt et al., 2005; Kendzerska et al., 2014; Marin et al., 2005; Redline et al., 2010)
including hypertension (Nieto et al., 2000; O'Connor et al., 2009), and coronary heart
disease (CHD) (Drager et al., 2010; Gottlieb et al., 2010; Hla et al., 2015). As AMD is a
disease of the microvasculature it is important to understand the impact of SDB on the
cardiovascular system. Drager et al. (2010) have illustrated that SDB may be present in
>50% of subjects with hypertension. There is a strong scientific rationale as to why SDB
may be related to hypertension as the vascular endothelium may be sensitive to the
repeated decreased oxygen levels that occur in subjects with SDB (Ip, Tse, Lam, Tsang,
& Lam, 2004). Theoretical mechanisms include SDB causing endothelial cell dysfunction
and increased activation of the sympathetic nervous system, both of which have been
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cited as underlying causality (Ip, Tse, et al., 2004). The same underlying disease process
may be at play with AMD as the vascular endothelium in the eye is subject to the same
stressors as the systemic circulation and associations with AMD and hypertension have
been reported (Hyman, Schachat, He, & Leske, 2000).
Two population-based studies have provided important data on the impact of
sleep apnea in the United States. The Sleep Heart Health Study (SHHS) is a prospective
cohort study of the cardiovascular consequences of OSA (Quan et al., 1997). The
Wisconsin Sleep Cohort is a stratified random sample from the year 1988 that includes
state employees in Wisconsin between 30 and 60 years old (T. Young et al., 1993). In one
of the seminal publications to investigate the association of SDB and hypertension, Nieto
et al. (Nieto et al., 2000) performed a cross-sectional analysis of the SHHS. The primary
exposure in this study was measured by AHI and the outcome of interest was
hypertension (blood pressure >140/90) (Nieto et al., 2000). In this study prevalence of
hypertension increased significantly with increasing SDB measures, although the authors
point to the fact that at least some of the association was explained by body mass index
(BMI). After adjusting for potential confounding variables, the OR for hypertension,
comparing the highest category of AHI (AHI >30) with the lowest category (AHI<1.5),
was 1.37 (95% confidence interval [CI, 1.03-1.83; P=.005)] (Nieto et al., 2000).
O’Connor et al. (2009) reported on the association of hypertension with SDB (AHI<5) in
the SHHS. In this study, the odds ratio (OR) for hypertension increased in relation to
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increasing baseline AHI. Although the authors conclude that much of the relationship can
be accounted for by baseline BMI (O'Connor et al., 2009).
Kenderska et al. (Kendzerska et al., 2014) performed a retrospective cohort study
using a clinical database from major academic institution in Canada looking at the impact
of SDB on a composite CVD outcome (myocardial infarction, stroke, congestive heart
failure, revascularization procedures, or death from any cause). Cox regression models
were used to analyze the association between baseline OSA and the composite outcome,
while controlling for traditional risk variables. AHI was significantly associated with
event-free survival in univariate analyses when treated as a continuous predictor in their
model [HR= 1.49, 95% CI: 1.42–1.57; p<0.001] (Kendzerska et al., 2014). Even after
controlling for a number of CVD risk factors (age, sex, smoking status, BMI, AHI) the
association between AHI as a continuous variable and the composite outcome of
remained statistically significant (HR= 1.12; 95% CI: 1.05–1.2, p<0.001).
Yeboah et al. (Yeboah et al., 2011) investigated the association between OSA and
CVD in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. The sample for this
study included 6814 men and women aged 45–84 years old from United States
communities with diverse ethnic backgrounds. This provided a population that consisted
of participants who were 38% White, 28% Black, 22% Hispanic, and 12% Chinese
(Yeboah et al., 2011). The primary exposure in this study was AHI and the outcome of
interest was CVD events (defined as CVD events that were adjudicated by a committee
of physicians). When compared healthy participants, those with OSA were associated
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with high CVD event rates in both univariate and multivariate models [hazard ratio
(95%); 1.89(1.22–2.93), p = 0.004 and 1.91(1.20–3.04), p = 0.007, respectively] (Yeboah
et al., 2011).
SDB and CVD
Marshall et al. (2014) studied 400 participants in Australia to investigate as to
whether SDB increased the risk of stroke, all-cause mortality, CVD, and CHD. The
primary exposure in this study was the respiratory disturbance index (RDI) and the
outcome of interest was the prevalence of ischemic stroke (Marshall et al., 2014). OSA
severity was quantified at a single night portable home PSG in 1990 and then participants
were followed up in 2010. Moderate-severe OSA was statistically associated with allcause mortality (HR = 4.2; 95% CI 1.9, 9.2) and stroke (3.7; 1.2, 11.8), but not associated
with CVD (1.9; 0.75, 4.6) or CHD incidence (1.1; 0.24, 4.6) (Marshall et al., 2014). The
authors comment that although the prevailing thought is that sleep apnea is thought to
increase mortality through cardiovascular disease, the association was not statistically
significant in this study (Marshall et al., 2014).
The SHHS study showed a significant positive association between stroke and
AHI was in men (p=0.016) (Redline et al., 2010). Men in the highest AHI quartile (>19)
had an adjusted hazard ratio of 2.86 (95% confidence interval, 1.1–7.4). In the mild to
moderate range (AHI, 5–25), each one-unit increase in AHI in men was estimated to
increase stroke risk by 6% (95% confidence interval, 2–10%). In women, stroke was not
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significantly associated with AHI, but there was an increased risk observed when the AHI
was > 25 (Redline et al., 2010).
Arzt et al. (Arzt et al., 2005) performed cross-sectional, longitudinal analyses on
subjects from the Wisconsin Sleep Cohort. The primary exposure in this study was
measured by AHI and the outcome of interest was stroke. In the study, participants with
an AHI of ≥20 or greater had increased odds for stroke (OR=4.33; 95% confidence
interval, 1.32– 14.24; p <0.02) compared with those without SDB (AHI <5) after
adjustment for known confounding factors (Arzt et al., 2005).
The previous studies illustrated association between OSA and stroke, although
their patient population represented middle-aged persons that may not be representative
of the elderly population. To investigate whether OSA is associated with stroke in this
population, Munoz et al. (2006) performed a prospective longitudinal study in elderly
subjects from Spain. The primary exposure in this study was measured by AHI and the
outcome of interest was stroke (Munoz et al., 2006). In subjects with severe OSA
(defined as AHI > 30) at baseline had a statistically significant risk of stroke (hazard
ratio= 2.52, 95% CI= 1.04 to 6.01, P= 0.04) (Munoz et al., 2006).
SDB and CHD
Hla et al. (2015) reported findings from the Wisconsin Sleep Cohort Study on the
association of CHD and SDB. This study investigated 1,131 adults over the age of 30
who completed one or more overnight sleep studies, which were free of CHD baseline,
and were not treated by CPAP. Participants were then followed longitudinally for 24
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years. The primary exposure in this study was measured by AHI and the outcome of
interest was CHD or heart failure (HF) (Hla et al., 2014). Participants with untreated
severe SBD (AHI > 30) were 2.6 times more likely to have CHD or heart failure
compared to those without SDB (Hla et al., 2015).
Gottlieb et al. (2010) reported an association of CHD with SDB in the SHHS. In
their study, they investigated 1927 men and 2495 women >40 years of age and free of
coronary heart disease and heart failure at the time of study entry (Gottlieb et al., 2010).
Subjects were followed for a median of 8.7 years. The primary exposure in this study was
measured by AHI and the outcome of interest was CHD (Gottlieb et al., 2010). OSA was
shown to be a significant predictor of CHD only in men ≤70 years of age (adjusted
hazard ratio 1.10 [95% confidence interval 1.00 to 1.21] per10-unit increase in apneahypopnea index [AHI]) but not in men >70 or in women of any age. In men age 40 to 70
years old, those participants that had AHI >30 were 68% more likely to develop CHD
than those with AHI <5 (Gottlieb et al., 2010).
SDB Epidemiology
As with AMD, the estimated prevalence numbers for SDB have a broad range,
likely based on the methodology and definitions for determining the presence of disease
(Franklin et al., 2013; Heinzer et al., 2015; Peppard et al., 2013; T. Young et al., 1993).
One of the highest prevalence estimates comes from Franklin et al. (2013) in a study of
OSA in a Swedish population-based random sample of 10,000 women. The authors
report that OSA (defined as AHI ≥5) occurs in 50% (95% CI 45–55%) of females aged
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20–70 yrs. 20% of females have moderate (defined as AHI 15-<30) and 6% severe sleep
apnea (defined as AHI ≥30). In those participants 55-70 years old or with a BMI ≥ 30
kg/m2 severe sleep apnea was present in 14% (95% CI 8.1–21%) and 31% (95% CI 12–
50%) of the population, respectively (Franklin et al., 2013). The higher estimates in this
study may be due to the fact that home PSG was used to measure AHI and the
measurement was not performed in a standardized clinical setting.
Heinzer et al. (2015) studied a population of 3043 participants in Lausanne,
Switzerland. Participants were examined with PSG in a University Hospital setting and
moderate to severe SDB was defined as AHI ≥15. The prevalence of moderate-to-severe
SDB was 23.4% (95% CI: 20.9–26.0) in women and 49.7% (95% CI: 46.6–52.8) in men.
There was a statistically significant difference across all categories of SDB based on
those <60 versus ≥60 and men vs. women (Heinzer et al., 2015).
The Wisconsin Sleep Cohort Study estimated the prevalence of OSA in a random
sample of 3,513 US employees in Wisconsin ages 30-60 years (T. Young et al., 1993).
Participants were observed during an overnight PSG examination. The estimated
prevalence of SDB (defined as AHI ≥5) was 9% for women and 24% for men. Peppard et
al. (2013) investigated this same population during the periods of 1988–1994 and 2007–
2010. The authors estimate moderate to severe SDB (AHI ≥15) are 10% (95% CI: 7-12)
among 30–49-year-old men; 17% (95% CI: 15-21) among 50–70-year-old men; 3% (95%
CI: 2, 4) among 30–49-year-old women; and 9% (95% CI: 7, 11) among 50–70 year-old
women (Peppard et al., 2013). These results indicate that over the two decade study
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period, there was between a substantial increase in SDB in the U.S. population (Peppard
et al., 2013).
A number of epidemiological studies have been performed in populations that
predominantly consist of ethnicities other than Caucasian. In a study of middle age Indian
men, the prevalence of OSA was 19.5% (Udwadia et al., 2004). In a population-based
sample from Korea, the prevalence of SDB was 27% and 16% in men and women,
respectively (Kim et al., 2004). In a study of middle-aged Chinese men and women living
in Hong Kong the prevalence of SDB was 8.8% and 3.7%, respectively (Ip et al., 2001;
Ip, Lam, et al., 2004).
AMD and SDB
As humans age, there is evidence that the quality of sleep deteriorates (Bloom et
al., 2009). Changes in circadian rhythms, the sleep–wake cycle, and decreased synthesis
of melatonin may all contribute to this phenomenon (Bloom et al., 2009; Rosen et al.,
2009). There is clear evidence that SDB is associated with the development of
cardiovascular (Laaban et al., 2002; Lavie, Herer, & Hoffstein, 2000; Nieto et al., 2000;
Peker, Hedner, Kraiczi, & Loth, 2000; Peppard, Young, Palta, & Skatrud, 2000; Shahar
et al., 2001; Stone et al., 2016) and neurodegenerative diseases (Buratti et al., 2014;
Osorio et al., 2015; Yaffe, Nettiksimmons, Yesavage, & Byers, 2015). Experimentally, it
has been demonstrated that apnea leads to neuronal damage (apoptosis) in susceptible
regions of the brain (Fung, Xi, Zhang, Sampogna, & Chase, 2012; J. H. Zhang, Fung, Xi,
Sampogna, & Chase, 2009).
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One common mechanism that has been proposed to describe this relationship
between SBD and both cardiovascular and neurodegenerative diseases is vascular
impairment (Buratti et al., 2014). Similarly, vascular impairment has been proposed as a
possible mechanism for AMD pathogenesis (Boltz et al., 2010; Grunwald et al., 2005;
Remsch et al., 2000). Based on the high-energy demand of human retina, nature has
provided it with one of the greatest blood flow networks of any organ in the human body
relative to its size (Ames et al., 1992; Blasiak et al., 2014; Boltz et al., 2010; Remsch et
al., 2000; Sim & Fruttiger, 2013). This places the outer retina, which is avascular but
highly metabolic, in a vulnerable state when there is insufficient energy and low
oxygenation of the blood stream.
The eye allows researchers the ability to investigate microvascular changes in a
non-invasive manner, therefore providing a window on the health of the systemic
vasculature. Retinal arterioles are shown to be anatomically similar to cerebral and
coronary arterioles, and systemic disease can often be diagnosed from ophthalmic
examination or through the use of diagnostic techniques such as fundus photography,
fluorescein angiography, and optical coherence tomography (OCT) (Klein, Klein, &
Moss, 1997; T. Wong et al., 2001). In both the CHS and ARIC study cohorts, retinal
microvascular abnormalities are strongly and independently associated with hypertension
as evident by arteriolar narrowing (as measured by the arteriovenous ratio [AVR]) and
arteriovenous nicking (Sharrett et al., 1999; T. Wong et al., 2002). Although there is a
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significant relationship, it is unclear whether AVR and/or arteriovenous nicking are an
appropriate measure of disease.
Microvascular changes have been shown to be associated with SDB in the MultiEthnic Study of Atherosclerosis (MESA) study (M. Chew et al., 2016). Women that were
enrolled in the MESA study showed an association between SBD and narrower arterioles
[regression coefficient (β)= -5.76; 95 % CI: -8.51, -3.02] after adjusting for cardiometabolic risk factors. Although in men there was no association between SDB and
arteriolar caliber, there was an association with incident CVD (M. Chew et al., 2016).
The authors proposed that there may be a potential gender difference in the susceptibility
to microvascular disease in association with SDB (M. Chew et al., 2016).
Boland et al. (2004) performed a sub study of the Sleep Heart Health Study
(SHHS) that examined the relation between SDB (as measured by RDI) and retinal
microvascular abnormalities. The SHHS is a prospective cohort design study consisting
of subjects 40 years and older to investigate the association of SDB with cardiovascular
disease (Quan et al., 1997). The authors found that the overall prevalence of retinopathy
was slightly higher in people with higher RDI values, although after adjustment for age,
body-mass index, hypertension, diabetes, and other factors, the association no longer
held. The authors concluded that the weak association with SDB and early microvascular
dysfunction should be investigated further.
Boltz et al. (2010) tested the hypothesis that lower retinal blood flow (inducing a
hypoxic environment within the retina) may be associated with an increased risk of
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developing choroidal neovascularization in an observational longitudinal study. Their
research indicated that lower retinal blood flow had a statistically significant association
with progression to choroidal neovascularization. This supports the hypothesis that the
hypoxic environment created by SDB may also have an effect on the progression of
AMD.
In addition to the retina allowing for insight into microvascular changes in the
body, neurodegenerative changes in the eye have can also be examined, quantified, and
imaged non-invasively in individuals with SDB (Huseyinoglu et al., 2014; Shiba et al.,
2014; Xin, Wang, Zhang, Wang, & Peng, 2014). Huseyinoglu et al. (2014) investigated
101 subjects with OSA and 20 controls without OSA using OCT to look at impact on the
retina nerve fiber layer (RNFL). The researchers performed PSG and ophthalmologic
examination including visual field (VF) testing. Subjects were graded based on PSG
score and placed into mild, moderate, and severe OSA categories. The researchers found
that there was a significant reduction in RNFL thickness in the subjects with severe OSA
compared with the other categorized groups. Shiba et al. (2014) corroborated these
findings in a study of 124 consecutive subjects who underwent PSG and OCT to measure
RNFL thickness, foveal thickness, and total macular volume. Their findings indicate that
the RNFL thickness was correlated with higher AHI values (Shiba et al., 2014). PSG
findings were not correlated with foveal thickness or total macular volume. These
findings have been corroborated in other research studies illustrating that thinning of the
retina and choroid occurs with increasing OSA severity (Xin et al., 2014). Similar to the
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aforementioned retinal findings, multiple studies investigating the morphological changes
in brains of subjects with OSA have shown that the volume of cortical gray matter is
smaller in patients with OSA as compared to controls (Branger et al., 2016; Morrell et al.,
2003; Torelli et al., 2011; Yaouhi et al., 2009).
Another important pathological finding that is shared by subjects with AMD or
SDB is the accumulation of amyloid-beta (Aβ) in the retina (Mullins et al., 2000; OhnoMatsui, 2011; Ratnayaka, Serpell, & Lotery, 2015) and brain, respectively (Branger et al.,
2016; Sprecher et al., 2015). Retinal ganglion cells (RGC) and the retinal pigment
epithelial layer have been identified as a source Aβ deposition within the retina as a
component of drusen (Ohno-Matsui, 2011). Amyloid plaques in the brain have been
shown to be a hallmark of Alzheimer’s disease (Jack et al., 2013). Branger et al. (2016)
have illustrated that Aβ accumulation in the brain, as assessed by structural MRI and
florbetapir-PET scans, was associated with worse self-reported sleep quality. Sprecher et
al. (2015) found similar results in participants enrolled in the Wisconsin Registry for
Alzheimer’s Prevention (WRAP). Results illustrated that participants with the perception
of less adequate sleep, more sleep problems, and greater somnolence had a greater brain
amyloid burden (Sprecher et al., 2015). In this study, Aβ was not associated with reported
sleep amount, symptoms of SDB, trouble falling asleep, or the Epworth Sleepiness Scale
(ESS) score (Sprecher et al., 2015). This phenomenon has been noted in other studies
imaging Aβ deposition in the brain of those with symptoms of SDB (Spira et al., 2014).
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As stated by Blasiak et al. (2014) “it is hard to determine whether any particular
pathology is linked with the stress caused by a risk factor or if it is a consequence of the
pathology or a combination of both”. Oxidative stress is defined as an imbalance with the
production of reactive oxygen species (ROS) and antioxidant defenses against those free
radicals (Betteridge, 2000). Cells have the ability to combat free radicals in most acute
situations, although in chronic situations tissue damage can ensue that may be irreversible
(Blasiak et al., 2014). The retina is constantly producing waste products from the
reactions that transpire when light energy causes photochemical reactions with the
photoreceptors. The retina has innate mechanisms of autophagy (intracellular mechanism
of waste removal) to remove these waste products by the retinal pigment epithelial layer.
Blasiak et al. (2014) proposes that any event that impairs blood flow to the retina or
reduces retinal oxygenation (SDB, smoking, COPD for example) will induce hypoxia
thus impairing the normal autophagy function within the retina, resulting in the build-up
of waste products. This build-up of waste products in AMD (drusen for example) can
cause a mechanical impairment of the transmission of signals from photoreceptors to the
appropriate processing centers in the brain (Blasiak et al., 2014). Oxidative stress has
been implicated as the cellular mechanism by which smoking is associated with AMD
(Marazita, Dugour, Marquioni-Ramella, Figueroa, & Suburo, 2015). Marazita et al.
(2015) demonstrated that exposure of human retinal pigment epithelial cells to a cigarette
smoke concentrate enhanced ROS levels and caused DNA damage. In their experiment,
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interleukin-6 (IL-6), IL-8, and VEGF levels were increased and CFH expression was
downregulated (Marazita et al., 2015).
SDB and Treatment for AMD
SDB has also been shown to interfere with current anti-VEGF treatments for
neovascular AMD. Barak et al. (2012) analyzed the functional and anatomical response
to treating choroidal neovascularization with anti-VEGF therapy with Avastin® in
patients before and after treatment of OSA. Untreated OSA in this study hampered the
response to anti-VEGF therapy for the treatment of neovascular AMD. After CPAP
therapy, the anatomical improvement provided by anti-VEGF treatment was evident,
although functional vision improvement did not follow. Nesmith, Ihnen and Schaal
(2014) looked at 103 patients with AMD compared to age-matched controls with regard
to treatment response to anti-VEGF therapy. Symptoms associated with OSA were
collected using the Berlin Questionnaire (BQ). The authors found that 30% of subjects
with AMD that had a poor response to anti-VEGF therapy were at a significantly higher
risk of OSA as assessed by the BQ (p< 0.05) (Nesmith et al., 2014).
SDB Associations with AMD
Recently, a number of studies have looked at whether sleep-associated variables
are associated with AMD (Keenan et al., 2016; Khurana et al., 2016; Perez-Canales et al.,
2016). Khurana et al. (2016) administered a prospectively designed sleep history
questionnaire to 1,003 consecutive patients in a private retina practice. Participants were
graded and placed into categories of no AMD, early AMD, nAMD, or geographic
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atrophy using the modified Wisconsin Age-Related Maculopathy Grading System. Using
multivariate analysis (controlling for age, gender, and smoking history), sleep hours were
not associated with nAMD (p = 0.97) as compared to controls. Sleeping >8 hours was
associated with GA (p = 0.02) when compared with patients without AMD (age-adjusted
OR=7.09; 95% confidence interval, 1.59–31.6) (Khurana et al., 2016). The strength of
this study is a large sample size as well as grading of retinal findings from fundus
photographs. One of the weaknesses of the study is the questionable generalizability as
all subjects were recruited from one clinic located in one geographic area.
Perez-Canales et al. (2016) performed a case control study that found a
statistically significant association between sleep duration and AMD (for <6 hours,
OR=3.29, 95% confidence interval 1.32–8.27; for 6–7 hours, OR= 2.25, 95% CI 0.80–
6.32; and for >8 hours, OR=1.39, 95% CI 0.53–3.73) compared with the reference
category of 7–8 hours. In addition, the highest utilization of sleep medication was being
used in the population with AMD (p < 0.001). The results of the study remained
statistically significant after adjustment for smoking status, history of depression, regular
physical activity, BMI and hypertension (Perez-Canales et al., 2016). This trend towards
a higher risk of nAMD in subjects with both short and long sleep duration when
compared with those in the 7–8 hours group suggests a possible U-shaped relationship
between sleep duration and nAMD (Perez-Canales et al., 2016). This study did not
investigate the association of sleep duration and GA.
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Keenan et al. (2016) linked English national hospital episode statistics (HES) for
248,408 patients with AMD that were admitted to English National Health Service
(NHS) treatment facilities and also had OSA. Their results showed that OSA was
positively associated with AMD (Keenan et al., 2016). The authors accounted for obesity
as a potential confounder in the analysis, although it had little effect on the association.
The strength of this study is that it includes a large number of participants from a major
healthcare system, although as with many of the other studies AMD severity was not
categorized.
Several studies have documented the association between SDB and other
ophthalmological diseases, including nonischemic anterior optic neuropathy,
chorioretinopathy, floppy eyelid syndrome, primary open-angle glaucoma, normaltension glaucoma, and papilledema. There are several studies showing association
between SDB and glaucomatous changes in the optic nerve characterized by optic nerve
head changes (Casas et al., 2013), visual field defects, and RNFL thickness (Casas et al.,
2013; Ferrandez et al., 2016; Lin et al., 2011) in light of the intraocular pressure (IOP)
being normal.
Confounders
AMD and SDB share similar potential confounders that include age, gender,
obesity, and past and current smoking status. Age is the most strongly associated risk
factor for AMD and in concert with obesity is the most important risk factor for SDB.
SDB has been shown to reach peak prevalence in the 45-64 year old age group (Bixler et
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al., 1998), while AMD has been shown to increase in prevalence with increasing age (E.
Chew et al., 2014; Tomany et al., 2004). Gender is a potential confounder in both
diseases as with AMD there is a slightly higher prevalence in women (E. Chew et al.,
2014; Tomany et al., 2004), whereas SDB is more prevalent in men (Heinzer et al., 2015;
Peppard et al., 2013). There have been reports that menopausal status may influence the
prevalence estimates of SDB and this same confounding has been suggested with AMD
(Bixler et al., 2001; Tomany et al., 2004). Obesity is strongly associated with SDB,
whereas the association with AMD is weak (Q. Zhang et al., 2016). In studies of SDB
and AMD where obesity was taken into account as a confounder, the effect on the
association was minimal (Keenan et al., 2016). Smoking is strongly associated with both
AMD (E. Chew et al., 2014) and SDB (Varol et al., 2015). In both diseases, smoking is
associated with earlier onset of disease and worse severity. Race/ethnicity is likely a
stronger confounder for AMD than SDB as strong associations with AMD and
participants of European ancestry have been reported (W. Wong et al., 2014). Smoking is
shown to be strongly associated with AMD and studies have shown an association with
SDB (Varol et al., 2015). Based on the shared confounders listed above it was important
to control for these variables in the analyses that I discuss in more detail in Chapter 3.
Summary
In summary, the current research is inconclusive on the association between SDB
and AMD and SDB and AMD severity. One of the main limitations to date has been the
lack of a population-based research study to investigate the association between the two
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diseases. In addition, there is no study to date that uses masked grading of retinal
photographs to determine AMD severity and analyze these findings in light of a sleep
questionnaire with multiple sleep related variables. Therefore, this study includes a large
sample from the NHANES 2005–2008 survey period that includes fundus photography
determined AMD status using masked graders and a validated grading protocol and a
sleep questionnaire to capture self-reported variables for SDB. I will detail the
methodology and analyses in Chapter 3.
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Chapter 3: Research Method
Introduction
The purpose of this quantitative cross-sectional study was to evaluate the
association between SDB and AMD in noninstitutionalized U.S. adults from 2005-2008
and to serve as proof of concept to promote future research on causality. In Chapter 3, I
present the study design and describe the study population, criteria for sample selection,
definition of variables, data collection methodology, and instrumentation and materials. I
also cover the NHANES 2005–2008 dataset and data analysis, the ethical protection of
participants; and the Institutional Review Board () review and approval.
Research Design and Rationale
To address the research questions related to the purpose of this research, I
investigated whether respondents with SDB (independent variable) had an increased
prevalence of AMD (dependent variable) using nationally representative data, both with
and without controlling for confounders. Cross-sectional study designs have been
commonly used to study associations between dependent and independent variables using
population-based surveys such as NHANES (Creswell, 2014). There were no time or
resource constraints for this study.
Research Hypotheses
The research questions and associated hypotheses that will guide this study are as
follows:
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Research Question 1: Is there an association between self-reported SDB and
fundus photography identified AMD among adults 40 years and older who participated in
the 2005–2008 NHANES survey before and after controlling for age, smoking, and BMI?
H01: There is no association between self-reported SDB and fundus photography
identified AMD among adults 40 years and older who participated in the NHANES 2005
to 2008 survey before and after controlling for age, smoking, and BMI.
H11: There is an association between self-reported SDB and fundus photography
identified AMD among adult 40 years and older who participated in the NHANES 2005
to 2008 survey before and after controlling for age, smoking, and BMI.
Research Question 2: Is there an association between self-reported SDB and
fundus photography identified neovascular AMD among adults 40 years and older who
participated in the 2005–2008 NHANES survey before and after controlling for age,
smoking, and BMI?
H02: There is no association between self-reported SDB and fundus photography
identified neovascular AMD among adults 40 years and older who participated in the
NHANES 2005 to 2008 survey before and after controlling for age, smoking, and BMI.
H12: There is an association between self-reported SDB and fundus photography
identified neovascular AMD among adult 40 years and older who participated in the
NHANES 2005 to 2008 survey before and after controlling for age, smoking, and BMI.
Research Question 3: Is there an association between self-reported SDB and
fundus photography identified geographic atrophy among adults 40 years and older who
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participated in the 2005–2008 NHANES survey before and after controlling for age,
smoking, and BMI?
H03: There is no association between self-reported SDB and fundus photography
identified geographic atrophy among adults 40 years and older who participated in the
NHANES 2005 to 2008 survey before and after controlling for age, smoking, and BMI.
H13: There is an association between self-reported SDB and fundus photography
identified geographic atrophy among adult 40 years and older who participated in the
NHANES 2005 to 2008 survey before and after controlling for age, smoking, and BMI.
Methodology
Population
This study comprises adults 40 years and older that participated in the NHANES
survey during the sampling timeframes of 2005-2006 and 2007-2008. The NHANES
survey period of 2005–2008 is unique in that these two sampling frames include digital
fundus photographs captured at a mobile examination center (MEC). Participants
included in this study provided responses to the Sleep Disordered Questionnaire (SLQ)
and had digital fundus photographs acquired as a part of NHANES. The population is
comprised of noninstitutionalized individuals from the 50 states and the District of
Columbia. The NHANES dataset does not include active duty military members by
design (Zipf et al., 2013).
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Sampling and Sampling Procedures
The NHANES survey uses a multistage probability sampling design to select a
sample representative of the civilian noninstitutionalized household population of the
United States (Zipf et al., 2013). Sample selection, collection, and cleaning procedures
for NHANES has been previously published (Zipf et al., 2013).
An a priori power analysis was conducted to determine an adequate sample size
using G*Power 3.1 (Faul, Erdfelder, Buchner, & Lang, 2009). Assumptions in
determining minimum sample size included a two-tailed alpha of 0.05 and a power of
90% to detect a weak association indicated by an OR of 1.2 (Monson, 1990). Monson
(1990) indicates that an OR below 1.2 indicates no association. Therefore an OR of 1.2
was used to estimate the minimum sample size needed; which was 1984 participants.
According to Klein et al. (2011), 5553 participants that were ≥40 years of age in the
2005–2008 NHANES dataset had at least 1 eye that could be evaluated for AMD. As
nAMD and geographic atrophy (late AMD) are only present in a small portion of the
population, the entire sample of participants that were ≥40 years of age, had at least 1 eye
that could be evaluated for AMD, and completed the sleep disorder questionnaire will be
included in the analyses.
Procedures for Recruitment, Participation, and Data Collection
The NHANES Survey is a national survey conducted by the National Center for
Health Statistics and consists of a representative sample of the noninstitutionalized and
civilian population of the United States. The first National Health Examination Survey
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(NHES-1) was performed in 1959 (Zipf et al., 2013). During the years 1959-1970 the
survey was performed periodically. As of 1999, the data has been continuously collected
during concurrent sampling timeframes. The goals of this continuous survey is to provide
prevalence data on selected diseases and risk factors for the U.S. population, to monitor
trends in selected diseases, behaviors, and environmental exposures, to explore emerging
public health needs, and to maintain a national probability sample of baseline information
on health and nutritional status in the United States (Zipf et al., 2013). The NHANES is a
unique survey as it not only contains participants’ self-reported health information from
survey instruments, but also information from physical examinations and laboratory tests
(Zipf et al., 2013). The participant interviews are conducted in the home, while the
physical examinations are performed at a MEC. The combination of self-reported health
information, physical examinations, and laboratory tests allows for analyses to be
performed that would otherwise not be possible, or as accurate, with self-reported
information alone (Zipf et al., 2013). Datasets from the NHANES survey are publically
available and can be downloaded from the CDC website
(http://www.cdc.gov/nchs/nhanes/).
The MEC was used to collect retinal fundus images to assess the prevalence of
vision loss and retinal diseases, such as AMD. Digital fundus photography was
performed to obtain two 45° digital retinal images for each eye of NHANES participants
involved in this ancillary study using the Canon CR6 non-mydriatic camera with a Canon
10D camera back (6.3 megapixels per image) (CDC, 2005). Masked grading of digital
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fundus photos eliminates recall bias that would otherwise be present from participant
self-report, although this does not completely rule out the potential for misclassification
bias that will be discussed further in this chapter. As this study investigated AMD as an
ordinal variable, the grading of fundus photos will allow for the diagnosis of early signs
of AMD that often do not cause visual disturbance in the patient and may not be
communicated in survey findings alone.
Operationalization of Variables
The dependent variables for this study depend upon the research questions asked
and included AMD status (categorical-none, early, and late AMD), nAMD, and
geographic atrophy as defined by masked fundus photo grading. The independent
variables included demographic variables (age, gender, race, BMI), diabetes status,
smoking status (past or current smoker) and SDB variables (sleep apnea, sleep apnea
symptoms of snoring and snorting/stop breathing, insomnia, short sleep duration, and any
sleep disorder diagnosed by a physician or other health professional).
Dependent variables (AMD, geographic atrophy, and choroidal
neovascularization). The following AMD Variables are defined from masked grading of
fundus photos as specified in the NHANES Digital Grading protocol and illustrated in
Table 2 (CDC, 2005). Definitions for No AMD, Early AMD, and Late AMD are defined
in the NHANES Digital Grading Protocol and this approach has been used in other
NHANES research (Klein et al., 2011). No AMD is defined as gradable images without
evidence of lesions associated with AMD. Early AMD was defined by the presence of
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either soft indistinct drusen or the presence of retinal pigment epithelial depigmentation
or increased retinal pigment, together with any type of drusen, or by the presence of soft
drusen with an area of 500 μm or larger in absence of signs of late AMD. Late AMD was
defined by the presence of any of the following: geographic atrophy or retinal pigment
epithelial layer detachment, subretinal hemorrhage or visible subretinal new vessels,
subretinal fibrous scar or laser treatment scar, or self-reported history of photodynamic or
anti–vascular endothelial growth factor treatment for exudative AMD. I present these
definitions in Table 2.
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Table 2
AMD Variables: NHANES 2005-2008
Data
Variable
variable
category
OPDUARM No AMD

Definition

OPDUGA

Gradable images with no evidence of
lesions associated with AMD.
Defined as either soft drusen present
with a grid area of greater than a 500μm
circle and a pigmentary abnormality
present (increased pigment or
depigmentation in the grid) or soft
drusen present in the center circle and a
pigmentary abnormality is present
(increased pigment or depigmentation in
the grid). No evidence of late AMD as
defined below will be present.
Defined as the presence of any late
lesions, such as GA, PED/RD
detachments, subretinal hemorrhage,
subretinal fibrous scar, subretinal new
vessels, or laser treatment and/or
/photodynamic therapy for AMD.
Geographic Atrophy

OPDUEXU

Exudative AMD

Early
AMD

Late
AMD

Variable
recode
0
1

2

Absent = 0
Present = 1
Absent = 0
Present = 1

Independent variables (SDB variables). SDB variables were based on
participant self-report and came from the NHANES 2005–2008 sleep disorders
questionnaire (SLQ). Previously published NHANES research has used this dataset and
categorized the SDB variables in a similar fashion to what was done for this study (Chen
et al., 2014; Seicean, Neuhauser, Strohl, & Redline, 2011). SDB variables were placed in

72
the following high-level categories: sleep apnea, SDB symptoms, insomnia, and insomnia
symptoms. Sleep apnea was defined based on answering in the affirmative to following
question: “Have you ever been told by a doctor or other health professional that you have
a sleep disorder: sleep apnea?” SDB symptoms were captured from questions on
duration of sleep, habitual snoring, and snorting/stop breathing. Sleep duration was
dichotomized to ≥6 hours vs. <6 hours. Habitual snoring was asked using the question:
(1) “In the past 12 months, how often did you snore while you were sleeping?”.
Snorting/Stop Breathing was collected using the question: “In the past 12 months, how
often did you snort, gasp, or stop breathing while you were asleep?”. Participants who
responded with “frequently (five or more nights per week)” were considered as having
“habitual snoring” and “snorting/stop breathing,” respectively. Those participants that
responded with “never,” “rarely (1-2 nights/week),” or “occasionally (3-4 nights/week)”
were considered as having no snoring or snorting/stop breathing, respectively. Insomnia
was defined based on answering yes to the following: “Have you ever been told by a
doctor or other health professional that you have a sleep disorder (Insomnia)?” Insomnia
symptoms were based on the answers to the following questions: “Do you have trouble
falling asleep” (sleep latency) and “Do you wake up during the night and had trouble
getting back to sleep” (nocturnal awakenings). A response to each insomnia symptom
question was categorized as follows: negligible (2-4 times per month or less), mild to
moderate (5-15 times per month), and severe (>15 times/month). These variables are
presented in Table 3.
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Table 3
SDB Variables: NHANES 2005-2008
Data set code
Sleep Apnea
SLQ.060

Question

Have you ever been
told by a doctor or
other health
professional that
you have a sleep
disorder?
SLQ.070
AND
What was the sleep
disorder?
Sleep Disturbed Breathing Symptoms
SLQ.010
How much sleep do
you usually get at
night on weekdays
or workdays?
SLQ.030
In the past 12
months, how often
did you snore while
you were sleeping?

SLQ.040

SLQ.120

In the past 12
months, how often
did you snort, gasp,
or stop breathing
while you were
asleep?
In the past month,
how often did you
feel excessively or
overly sleepy during
the day?

Response(s)

Study code
Sleep Apnea

Yes

AND Sleep Apnea

≥6 hours
<6 hours

Sleep
Duration

Habitual Snoring
(Frequently, ≥5 nights/week)
No Smoking (Never; Rarely,
1-2 nights/week;
Occasionally, 3-4
nights/week)
Snorting/Stop Breathing
(Frequently, ≥5 nights/week)
No Snorting/Stop Breathing
(Never; Rarely, 1-2
nights/week; Occasionally, 34 nights/week)
Severe (Almost always, 1630 times a month)
Mild to Moderate (Often, 515 times a month)
Negligible (Sometimes, 2-4
times a month; Rarely, 1
times a month; Never)

Snoring

Insomnia

Snort/Stop
Breathing

Hypersomnol
ence

Diagnosed
Insomnia
Continued
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Data set code
SLQ.060

Question
Have you ever been
told by a doctor or
other health
professional that
you have a sleep
disorder?
SLQ.070
AND What was the
disorder?
Insomnia Symptoms
SLQ.080
In the past month,
how often did you
have trouble falling
asleep?

SLQ.080

In the past month,
how often do you
wake up during the
night and have
trouble getting back
to sleep?

Response(s)
Yes

Study code

AND Insomnia

Severe (Almost always, 1630 times a month)
Mild to Moderate (Often, 515 times a month)
Negligible (Sometimes, 2-4
times a month; Rarely, 1
times a month; Never)
Severe (Almost always, 1630 times a month)
Mild to Moderate (Often, 515 times a month)
Negligible (Sometimes, 2-4
times a month; Rarely, 1
times a month; Never)

Sleep
Latency

Nocturnal
Awakenings

Sociodemographic and lifestyle characteristics. I present individual
demographic data based on participant self-report in Table 4. These include age, gender,
and race.
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Table 4
Demographic Variables: NHANES 2005-2008
Variable name Description
RIAGENDER

Gender

RIDAGEYR

Age in years of the
participant at the time
of screening.
Recode of reported
race and ethnicity
information.

RIDRETH1

BMXBMI

DIQ.010

Calculated BMI
(kg/m2)

Other than during
pregnancy, have you
ever been told by a
doctor or other health
professional that you
have diabetes or
sugar diabetes?

Level of
measurement
Binominal

Study
code
Gender

Nominal

Age

Nominal

Ethnicity

Nominal

Binominal

BMI

Diabetes

Variable recode
Male = 1
Female = 2
40-59
≥ 60
Mexican
American = 1
Other
Hispanic = 2
Non-Hispanic
White = 3
Black = 4
Other race = 5
Normal =
0-24.9
Overweight=
25.0-29.9
Obese = ≥30
Yes=1
No=2

Smoking history variables. Smoking status was based on participant self-report,
and was divided into three categories, “current smoker”, “past smoker”, and nonsmoker.
These variables are presented in Table 5. Current smokers were categorized as all
individuals who responded positively to smoking at least 100 cigarettes in a lifetime and
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smoking cigarettes every day or some days. Past smokers were categorized as those who
had smoked at least 100 cigarettes and who replied that they no longer smoked cigarettes.
A nonsmoker was categorized as any individual who had smoked fewer than 100
cigarettes in their lifetime.
Table 5
Smoking Variables: NHANES 2005-2008
Data set code
Current smoker
SMQ.020

SMQ.040
Past smoker
SMQ.020

SMQ.040
Nonsmoker
SMQ.020

Question

Response

Have you smoked
at least 100
cigarettes in your
entire life?
AND Do you now
smoke cigarettes?

Yes

Study code
Current smoker

AND Every day
OR Some days
Past smoker

Have you smoked
at least 100
cigarettes in your
entire life?
AND Do you now
smoke cigarettes?

Yes

AND Not at all
Nonsmoker

Have you smoked
at least 100
cigarettes in your
entire life?

No

Data Analysis Plan
Analyses was performed using SPSS software (IBM Corp. Released 2013. IBM
SPSS Statistics for Mac, Version 23.0. Armonk, NY: IBM Corp). Datasets from the
2005-2006 and 2007-2008 survey periods were merged to produce an analysis dataset.
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Variables were recoded, as needed, based on the specifications previously described in
the section on operationalization of variables.
The research questions and associated hypotheses that guided this study are as
follows:
Research Question 1: Is there an association between self-reported SDB and
fundus photography identified AMD among adults 40 years and older who participated in
the 2005–2008 NHANES survey before and after controlling for age, smoking, and BMI?
H01: There is no association between self-reported SDB and fundus photography
identified AMD among adults 40 years and older who participated in the NHANES 2005
to 2008 survey before and after controlling for age, smoking, and BMI.
H11: There is an association between self-reported SDB and fundus photography
identified AMD among adult 40 years and older who participated in the NHANES 2005
to 2008 survey before and after controlling for age, smoking, and BMI.
Research Question 2: Is there an association between self-reported SDB and
fundus photography identified neovascular AMD among adults 40 years and older who
participated in the 2005–2008 NHANES survey before and after controlling for age,
smoking, and BMI?
H02: There is no association between self-reported SDB and fundus photography
identified neovascular AMD among adults 40 years and older who participated in the
NHANES 2005 to 2008 survey before and after controlling for age, smoking, and BMI.
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H12: There is an association between self-reported SDB and fundus photography
identified neovascular AMD among adult 40 years and older who participated in the
NHANES 2005 to 2008 survey before and before and after controlling for age, smoking,
and BMI.
Research Question 3: Is there an association between self-reported SDB and
fundus photography identified geographic atrophy among adults 40 years and older who
participated in the 2005–2008 NHANES survey before and after controlling for age,
smoking, and BMI?
H03: There is no association between self-reported SDB and fundus photography
identified geographic atrophy among adults 40 years and older who participated in the
NHANES 2005 to 2008 survey before and after controlling for age, smoking, and BMI.
H13: There is an association between self-reported SDB and fundus photography
identified geographic atrophy among adult 40 years and older who participated in the
NHANES 2005 to 2008 survey before and after controlling for age, smoking, and BMI.
To answer these research questions, I first conducted a chi-square test for
association to determine any differences in the distribution of AMD across
sociodemographic, lifestyle, and sleep characteristics. Cumulative odds OLR with
proportional odds (ordinal dependent variable= no AMD, early AMD, late AMD)
regression and binomial logistic regression modeling (dependent variable=no choroidal
neovascularization, choroidal neovascularization present; no geographic atrophy,
geographic atrophy present) were fit to understand the association between AMD and
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sleep parameters with adjustment for sociodemographic and lifestyle factors. Survey
specific sampling design variables and sampling weights were incorporated in the
analyses to account for the complex multistage sampling design of NHANES. The two
main objectives of this OLR were as follows: (a) to determine which of the independent
variables (if any) have a statistically significant effect on AMD; and (b) determine how
well the OLR model predicts AMD. An OLR analysis was performed that only included
SDB variables (sleep apnea, sleep apnea symptoms of snoring and snorting/stop
breathing, insomnia, short sleep duration, and any sleep disorder diagnosed by a
physician or other health professional). The second model was adjusted for demographic
variables identified as confounders (age, BMI) and smoking status (past or current
smoker) and tested with a multivariable regression analysis. Binomial logistic regression
models were created to test the association with nAMD and geographic atrophy with
SDB, respectively. These binomial logistic regression models were adjusted for the same
independent variables as with the cumulative odds OLR with proportional odds analyses
listed above. In accordance with the number of analyses conducted, adjustment of the
significance level by the method of Sequential Sidak was incorporated. Data analyses
were performed using SPSS software using the Cross Tabs, Complex Samples OLR, and
Complex Samples Logistic Regression procedures (IBM Corp. Released 2013. IBM
SPSS Statistics for Mac, Version 23.0. Armonk, NY: IBM Corp). ORs and 95%
confidence intervals (95% CIs) were calculated for all models.
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Threats to Validity
The current study used data from the 2005–2008 NHANES sampling periods to
evaluate the association between AMD and SDB. The NHANES survey captures data
from a single point in time (cross-sectional) and therefore provided little to no basis for
assumptions about causality. Due to this limitation of the design, the study was only
interpreted in terms of illustrating an association between AMD and SDB.
NHANES participants are only sampled from the United States, so
generalizability to other populations may not be accurate (external validity). In addition,
the NHANES survey does not include individuals who were institutionalized (e.g.,
nursing home residents, incarcerated individuals, long term care facility residents) at the
time of the survey. Based on this study’s requirements for interpreted retinal fundus
photographs, I was unable to include a substantial number of participants who did not
have photographs taken, or for whom the photos taken were considered ungradable.
Participants that had no ability to perceive light, severe visual impairment in both eyes, or
an infection in at least one eye were excluded from fundus photography (CDC, 2005).
Lastly, due to the sampling timeframes and the limited years available in this analysis,
certain ethnic subgroups may be underestimated. NHANES provides ethnicity as a
recoded data variable with the categories of Mexican American, Other Hispanic, NonHispanic White, Non-Hispanic Black, and Other. As there is no granularity with regards
to the ethnicity/race in the Other categories, it was not possible to assess the association
with populations other than the recoded variable provided by NHANES. This may have
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had little impact on the analyses as AMD has a relatively high prevalence in the nonHispanic White population while it is relatively rare in Blacks and Latinos (Klein et al.,
2011). The entire available sample that met my inclusion criteria was analyzed regardless
of ethnicity.
Ethical Considerations
As this study used secondary data from persons who participated in the NHANES
survey, measures were employed to ensure participant protection prior to and during data
collection (Zipf et al., 2013). This study used de-identified data and there was and will be
no effort to contact those NHANES participants who are included in the study. In this
study, I used all available data that met the pre-specified inclusion criteria of ≥40 years of
age, had at least one eye that could be evaluated for AMD, and completed the sleep
disorder questionnaire.
The NHANES survey data is publicly available; it has been previously reviewed
by the NCHS Research Ethics Review Board [ERB] (CDC, 2016a). All subjects were
administered and provided informed consent prior to participation in NHANES. The
Walden University Institutional Review Board (IRB) provided a review and was
responsible for oversight for the analyses of this secondary data set (IRB approval
number 11-15-16-0260551). The anonymized data sets were downloaded from the
publically available NHANES website and stored on my local workstation with
appropriate back-up software in place. I will maintain the data for the latter of 3 years

82
after the publication of this dissertation and/or the publication of the results in a peerreviewed journal.
Summary
In Chapter 3, I provided the methodology to perform this quantitative, crosssectional study based on a life course approach to chronic disease. The primary objective
of this project was to identify if there is an association with AMD and SDB for
noninstitutionalized U.S. adults over the age of 40 from the NHANES sampling periods
2005-2008. The association was investigated in the context of demographic variables,
smoking variables, and SDB variables. The results of the current study may provide
patients, caregivers, and healthcare providers essential information for the prevention and
treatment of AMD.
Results, including the demographics of the sample and the findings gleaned from
my use of ordinal and binomial logistic regression are presented in Chapter 4.
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Chapter 4: Results
Introduction
The purpose of this quantitative cross-sectional study was to evaluate the
association between SDB and AMD in noninstitutionalized U.S. adults from 2005-2008
and to serve as proof of concept to promote future research on causality. To achieve this
purpose, I tested the hypotheses using secondary data from the 2005–2008 NHANES
survey sampling frames. A multistage probability sampling design was used by
NHANES to select a sample representative of the civilian, noninstitutionalized household
population of the United States that has been previously published in the peer reviewed
literature (Zipf et al., 2013).
In Chapter 4, I present the demographics of the study sample, bivariate
relationships between the dependent and independent variables, an evaluation of potential
confounders to that relationship, and the odds ratios determined through my use of
ordinal and binary logistic regression. The first hypothesis, testing the association
between SDB and AMD was assessed by performing a preliminary chi-square test for
association to determine any differences in the distribution of AMD across
sociodemographic, lifestyle, and sleep characteristics. Each SDB variable was then
incorporated into a complex samples OLR model with and without adjustment for
covariates. I used a multivariate model to incorporate the statistically significant SDB and
covariate variables to estimate the strength, significance, and direction of the primary
relationships. The second and third hypothesis testing the association between SDB and
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choroidal neovascularization and SDB and geographic atrophy, respectively, had to be
collapsed due to the rare prevalence of these two subpopulations in the study sample.
This resulted in a single research question addressing the association of SDB with late
AMD (choroidal neovascularization and geographic atrophy). Therefore, RQ 2 is as
follows: Is there an association between self-reported SDB and fundus photography
identified late AMD among adults 40 years and older who participated in the 2005–2008
NHANES survey before and after controlling for age, smoking, and BMI? This research
question was analyzed using the complex samples binary logistic regression model and
included the covariates age, BMI, and smoking status identified in in the assessment of
the first research question.
Data Collection
The source of secondary data for this study was the NHANES 2005–2008 survey.
The NHANES is an appropriate data collection tool as it utilizes sampling techniques to
survey a representative of the civilian noninstitutionalized household population of the
United States during each sampling timeframe (Zipf et al., 2013). The sampling design
for the 2005–2008 survey years has been previously described in detail in the peerreviewed literature (National Center for Health Statistics [U.S.], 2012, 2013). In
summary, a multistage sample design was used in NHANES 2005-2008. The first stage
of the sample design consisted of selecting the primary sampling units (PSU) from all
U.S. counties, using the 2000 U.S. Census Bureau data. The second sampling stage
divided each PSU into blocks or groups of blocks containing household clusters.
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NHANES oversampled specific populations that could be underrepresented with basic
survey methodology and are of particular public health interest. In the 2005-2006
sampling timeframe, Mexican-American, Black, low-income White, and other persons (at
or below 130% of federal poverty level); adolescents aged 12–19; and non-Hispanic
White and other adults aged 70 and over were oversampled (National Center for Health
Statistics [U.S.], 2013). In the 2007-2008 sampling timeframe Hispanic, non-Hispanic
Black, low-income non-Hispanic White, and other persons (at or below 130% of federal
poverty level); and non-Hispanic White and other adults aged 80 and over were
oversampled (National Center for Health Statistics [U.S.], 2013).
Results
Descriptive Characteristics
The NHANES survey is a national survey that collects data from approximately
5,000 participants within the U.S. population each year such that the data will enable
extrapolation to the U.S. population (CDC, 2011). A total of 10,348 participants were
included in the 2005-2006 NHANES survey; 9,950 and 398 participants were
administered interviews and examinations or interviews alone, respectively (CDC,
2009a). Data from these participants was collected from November 1, 2005 to October
31, 2006. A total of 10,149 participants were included in the 2007-2008 NHANES
survey; 9,762 and 387 participants were administered interviews and examinations or
interviews alone, respectively (CDC, 2009b). Data from these participants was collected
from November 1, 2007 to October 31, 2008. The sample for these analyses was limited
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to those survey participants that had data for both the dependent (AMD) and independent
variables (SDB). Only those survey participants that were 40 years and older were
eligible to have ophthalmology examinations, therefore by definition the sample only
included individuals above this age cut-off. The available cases for analyses are detailed
in Figure 4.

Figure 4. Participant flowchart detailing the number of cases available for
analysis.
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In Table 6, I report the frequencies and percentages of the sociodemographic
characteristics of the unweighted NHANES sample (n = 20,497), the unweighted study
sample (n=5,604) and the weighted study sample (n = 227,456,895). During the survey
periods 2005-2006 and 2007-2008, 20,497 participants were interviewed and/or
examined in NHANES. Only those participants ≥ 40 had the option of participating in the
ophthalmology-retinal imaging examination and therefore the available sample size for
this study was 5,604 participants (Figure 4). As AMD presents rarely before the age of 40
years, this inherent age cut-off due to the NHANES examination methodology did not
adversely alter the study sample. The weighted sample demographics are provided in
Table 6 to allow estimates of the parameters that would have been obtained were the
entire U.S. population surveyed (CDC, 2009b).
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Table 6
Sociodemographic characteristics of NHANES Sample, Study Sample, and Weighted
Study Sample
Characteristic

NHANES
Sample1,2
N=7,081
n (%)

Study Sample1
N=5604
n (%)

Weighted Study
Sample
N=227,456,895
(%)

40-59 3357 (47.4)
≥ 60 3724 (52.6)

2829 (50.5)
2775 (49.5)

64.4
35.6

3575 (50.5)
3506 (49.5)

2793 (49.8)
2811 (50.2)

52.6
47.4

3688 (52.1)

3017 (53.8)

77.1

1514 (21.4)

1139 (20.3)

9.6

518 (7.3)
1103 (15.6)
258 (3.6)

864 (15.4)
40 (7.2)
183 (3.3)

7.6
4.7
NA2

Age

Gender
Women
Men
Race/Ethnicity3
Non-Hispanic
White
Non-Hispanic
Black
Other Hispanic
Mexican American
Other race
Smoking status4

Nonsmoker 3433 (48.5)
2648 (47.3)
48.5
1812 (32.3)
30.9
Past smoker 2248 (31.8)
Current smoker 1391 (19.7)
1142 (20.4)
20.6
Diabetes status
No 5744 (81.2)
4643 (83.0)
87.4
Yes 1329 (18.8)
954 (17.0)
12.6
BMI
Normal 1724 (26.3)
1410 (25.7)
27.5
Overweight 2328 (35.5)
1973 (35.9)
35.3
Obese 2505 (38.2)
2109 (38.4)
37.2
1
Unweighted
2
NHANES sample of those participants >40 years of age
3
Weighted estimates not provided for “other race” category that includes multiple
ethnic groups.
4
Nonsmoker was defined as a respondent who had not smoked at least 100
cigarettes in their life; a past smoker was defined as a respondent who had smoked at
least 100 cigarettes in their life although do not now smoke cigarettes, current smoker
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defined as survey respondents who have smoked at least 100 cigarettes in their life and
now smoke cigarettes.
The sample included slightly more men (51.2%) than women. The sample also
include more Non-Hispanic Whites (51.2%) than the combined other races/ethnicities.
Half of the sample responded that they were nonsmokers, while 17% reported having
received a diagnosis of diabetes. Of note, a higher percentage of the sample was
identified as obese rather than overweight or normal based on the CDC definitions using
BMI.
As I was unable to use the entire sample for NHANES 2005–2008 due to the need
for the AMD grading, I used the chi-square Goodness of Fit test to compare my sample to
the NHANES sample over the age of 40. The results of this analysis are presented in
Table 7.
Table 7
Goodness of Fit Results from Comparison of NHANES and this Study’s Sample
Characteristic
Age
Gender
Race/ethnicity
Diabetes
BMI

Chi-square
0.64
0.04
17.01
0.26
0.21

p value
0.42
0.84
0.002
0.61
0.90

These results suggest that the sample I used was not significantly different from
the original sample in all sociodemographic variables except race/ethnicity. As the
weighting is based on the entire NHANES sample, I had to use caution in my
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interpretation of race/ethnicity. The impact of this is minimal in later analyses as only
age, smoking status, and BMI were included in my models as potential confounders.
Table 8 summarizes the SDB variables for the unweighted NHANES sample
(n=7,081), the unweighted study sample (n=5,604) and the weighted study sample
(n=227,456,895).
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Table 8
SDB characteristics of NHANES Sample, Study Sample, and Weighted Study Sample
Characteristic

NHANES
Sample1,2

Study Sample1

Weighted Study
Sample

N=7,081
N=5604
N=227,456,895
n (%)
n (%)
(%)
Any diagnosed sleep disorder3
No 6431 (90.8)
5088 (90.8)
95.3
Yes 650 (9.2)
516 (9.2)
4.7
Diagnosed sleep apnea
5260 (94.5)
97.4
No 6656 (94.7)
Yes 373 (5.3)
305 (5.5)
2.6
Snoring
No 3869 (62.6)
3048 (61.7)
70.0
Habitual 2315 (37.4)
1891 (38.3)
30.0
Snorting/stop breathing
No 5913 (93.1)
4705 (93.2)
97.1
343 (6.8)
2.9
Yes 435 (6.9)
Diagnosed insomnia
No 6905 (98.2)
5468 (98.3)
99.6
Yes 124 (1.8)
97 (1.7)
0.4
Prolonged sleep latency4
4624 (82.5)
83.1
Negligible 5825 (82.3)
Mild to moderate 658 (9.3)
512 (9.1)
8.0
Severe 591 (8.3)
466 (8.3)
8.9
4
Nocturnal awakenings
Negligible 5513 (78.0)
4351 (77.7)
75.9
753 (13.4)
15.0
Mild to moderate 918 (13.0)
Severe 640 (9.1)
499 (8.9)
9.1
4
Hypersomnolence
Negligible 5870 (83.1)
4675 (83.5)
82.3
Mild to moderate 754(10.7)
599 (10.7)
11.1
Severe 442 (6.3)
324 (5.8)
6.6
Sleep duration
≥6 hours 5916 (83.5)
4706 (84.0)
89.4
< 6 hours 1165 (16.5)
898 (16.0)
10.6
1
Unweighted
2
NHANES sample of those participants >40 years of age
3
Sleep Disorders categorized as sleep apnea, insomnia, restless leg syndrome, other
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4

Prolonged Sleep Latency, Nocturnal Awakenings, and Hypersomnolence defined as
Severe (Almost Always 16-30 times a month); Mild to Moderate (Often 5-15 times a
month); Negligible (Sometimes 2-4 times a month; Rarely 1 time a month; Never).

Nine percent of participants self-reported that they had been diagnosed with a
sleep disorder; 6% and 2% were diagnosed with sleep apnea and insomnia, respectively.
In contrast 38% of participants self-reported snoring more than 5 or more nights per week
and 18% reported receiving less than 6 hours of sleep on average.
There were more participants providing responses to the sleep questionnaire than
participated in the mobile examination center data collection of retinal fundus photos.
Therefore, the sample size of the study sample is limited by the availability of data from
the masked grading of fundus photos. Figure 5 illustrates the AMD demographics (worse
eye) based on grading performed using the modified Wisconsin Age-Related
Maculopathy Grading System. Overall the prevalence of any AMD in the study sample
was 7.9% with 6.9% categorized as early AMD and 1.0% as late AMD. Of the
participants with late AMD, 0.6% and 0.4% were graded as having geographic atrophy
and choroidal neovascularization, respectively.
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Figure 5. AMD demographics (worse eye) in 5604 participants in the NHANES
2005–2008 survey.
Research Question 1: Chi-Square Analyses
In the first research question, I asked whether there is an association between selfreported SDB and fundus photography identified AMD among adults 40 years and older
who participated in the 2005–2008 NHANES survey. A preliminary chi-square test for
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association was conducted between the presence or absence of AMD and
sociodemographic characteristics of the study sample. The results of these analyses are
presented in Table 9.
Table 9
Chi-square Test of Association between AMD and Sociodemographic Characteristics
Characteristic

No AMD
n=5163
n (%)

Any AMD
n=441
n (%)

Age

<.001
40-59 2753 (53.3)
≥ 60 2410 (46.7)

76 (17.2)
365 (82.8)

Gender

.439

Women
Men
Race/Ethnicity
Non-Hispanic
White
Non-Hispanic
Black
Other Hispanic
Mexican American
Other race
Smoking status2
Nonsmoker
Past smoker
Current smoker

2581 (50.0)
2582 (50.0)

212 (48.1)
229 (51.9)

2703 (52.4)

314 (71.2)

1103 (21.4)

36 (8.2)

376 (15.7)
811(3.3)
170 (7.3)

25 (12.0)
53 (2.9)
13 (5.7)

<.001

<.001
2451 (47.5)
1634 (31.7)
1076 (20.8)

197 (44.7)
178 (40.3)
66 (15.0)

Diabetes status

.791
No 4280 (83.0)
Yes 877 (17.0)

BMI3

p Value1

363 (82.5)
77 (17.5)

.021
Normal 1290 (25.5)
120 (27.8)
Overweight 1800 (35.6)
173 (40.0)
Obese 1970 (38.9)
139 (32.2)
1 2
χ test for association was conducted, p < .05
2
Nonsmoker defined as survey respondents that have not smoked at least 100 cigarettes in
their life, past smoker defined as survey respondents that have smoked at least 100
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cigarettes in their life although do not now smoke cigarettes, current smoker defined as
survey respondents that have smoked at least 100 cigarettes in their life although and now
smoke cigarettes.
3
BMI categories as defined by CDC
All expected cell frequencies were greater than five. There was a statistically
significant association between AMD and age, χ2 (df = 1) = 211.68, p < .001;
race/Ethnicity, χ2 (df = 4) = 66.86, p < .001; smoking status, χ2 (df =2) = 17.09, p <
.001; and BMI, χ2 (df =2) = 7.76, p = .021. There was no association between AMD and
gender or diabetes status. Thus, those variables were not included as potential
confounders in the remaining analyses.
A chi-square test for association was conducted between AMD and SDB
characteristics of the study sample. The results are presented in Table 10.
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Table 10
Chi-square Test of Association between AMD and SDB Characteristics
No AMD
Any AMD
p Value1
n=5163
n=441
n (%)
n (%)
Any diagnosed sleep disorder
.004
No 4671 (90.5)
417 (94.6)
Yes 492 (9.5)
24 (5.4)
Diagnosed sleep apnea
.015
No 4833 (94.3)
427 (97.0)
Yes 292 (5.7)
13 (3.0)
Snoring
.144
244 (65.2)
No 2804 (61.4)
130 (34.8)
Habitual 1761 (38.6)
Snorting/stop breathing
.022
No 4324 (93.0)
382 (96.0)
Yes 327 (7.0)
16 (4.0)
Diagnosed insomnia
.311
435 (98.9)
No 5033 (98.2)
Yes 92 (1.8)
5 (1.1)
Prolonged sleep latency2
.172
Negligible 4254 (82.4)
370 (83.9)
Mild to moderate 482 (9.3)
30 (6.8)
41 (9.3)
Severe 425 (8.2)
Nocturnal awakenings2
.503
Negligible 4014 (77.8)
337 (76.4)
Mild to moderate 695 (13.5)
58 (13.2)
Severe 453 (8.8)
46 (10.4)
2
Hypersomnolence
.230
Negligible 4318 (83.7)
357 (81.1)
Mild to moderate 549 (10.6)
50 (11.4)
Severe 291 (5.6)
33 (7.5)
Sleep duration
.087
≥6 hours 4323 (83.7)
383 (86.8)
< 6 hours 840 (16.3)
58 (13.2)
1 2
χ test for association was conducted, p <.05
2
Prolonged Sleep Latency, Nocturnal Awakenings, and Hypersomnolence defined as
Severe (Almost Always 16-30 times a month); Mild to Moderate (Often 5-15 times a
month); Negligible (Sometimes 2-4 times a month; Rarely 1 time a month; Never)
Characteristic
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All expected cell frequencies were greater than five. There was a statistically
significant association between AMD and self-reported diagnosis of any sleep disorder,
χ2 (1) = 8.119, p=.004; self-reported diagnosis of sleep apnea, χ2 (1) = 5.89, p=.015; and
self-reported snorting/gasping/stop breathing χ2 (1) = 5.25, p=.022. There were no
associations between AMD and snoring, insomnia, prolonged sleep latency, nocturnal
awakenings, hypersomnolence, or sleep duration.
Research Question 1: Complex Samples OLR. To address the hypotheses
associated with these research questions, I included the variable for the 3-level AMD
severity (dependent variable) and the nine SDB (independent variables) included
separately in the models and then adjusted for covariates. As NHANES uses a complex,
multistage, probability sampling design (including oversampling) to select participants, I
elected to use the Complex Samples OLR procedure in SPSS for analyses. Weighting
variables were applied to assure that the output is representative of the U.S. civilian
noninstitutionalized 2000 Census population (CDC, 2009a, 2009b). The dependent
variable was the categorical AMD severity scale (no AMD, early AMD, and late AMD)
determined from the grading of fundus photos. Independent variables were tested for
multicollinearity in SPSS using the linear procedure. All tolerance values were greater
than 0.1 (the lowest value was 0.639) and Variance Inflation Factor (VIF) values were
less than 10 (the highest value was 1.565), indicating that the assumption related to
multicollinearity was met. The results of the OLR models for the association of AMD
and SDB characteristics are presented in Table 11.
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Table 11
Ordinal Logistic Regression Models: Association of SDB and AMD
Outcome variable

Unadjusted
OR (95% CI)
2.2 (1.2-3.9)

Any diagnosed
sleep disorder
Diagnosed sleep
2.6 (1.4-5.1)
apnea
Snoring
1.5 (1.1-2.0)
Snorting/stop
2.8 (1.3-6.0)
breathing
Diagnosed
3.1 (1.1-9.0)
insomnia
Prolonged sleep latency
Mild to moderate 1.3 (0.8-1.9)
vs. Negligible
Severe vs. 0.9 (0.5-1.5)
Negligible
Nocturnal awakenings
Mild to moderate 1.0 (0.6-1.5)
vs. Negligible
Severe vs. 0.9 (0.6-1.4)
Negligible
Hypersomnolence
Mild to moderate 1.0 (0.6-1.7)
vs. Negligible
Severe vs. 0.8 (0.4-1.5)
Negligible
Sleep duration
1.3 (0.8-2.1)
1
2

p Value1
.009

Adjusted2
OR (95% CI)
2.0 (1.2-3.6)

p Value1
.015

.005

2.6 (1.3-4.9)

.006

.018
.010

1.3 (1.0-1.8)
2.4 (1.1-5.1)

.070
.024

.029

2.3 (0.9-6.4)

.095

.454

1.1 (0.7-1.7)

.430

.454

0.8 (0.5-1.3)

.430

.186

0.9 (0.6-1.4)

.693

.186

0.8 (0.6-1.1)

.693

.752

1.0 (0.5-1.6)

.444

.752

0.7 (0.3-1.3)

.444

.232

1.2 (0.8-1.8)

.493

Complex Samples Ordinal Logistic Regression was conducted, p < .05
The SDB variables were adjusted for age, BMI, and smoking status.
Models are presented unadjusted as well as adjusted for age, BMI, and smoking

status. Though race/ethnicity was significantly associated with AMD in the chi-square
analysis as presented in Table 9, this association was negated with the addition of the
SDB variables; thus, this variable was not included as a potential confounder in the
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multivariate analysis. Participants with AMD were associated with self-reported
diagnosis of any sleep disorder (OR, 2.2; 95% CI, 1.2-3.9), self-reported diagnosis of
sleep apnea (OR, 2.6; 95% CI, 1.4-5.1), and self-reported snorting/stop breathing (OR,
2.8; 95% CI, 1.3-6.0). Association between AMD and snoring (OR, 1.5; 95% CI, 1.1-2.0)
and between AMD and Insomnia (OR, 3.1; 95% CI, 1.1-9.0) were significant in
unadjusted models, although once I controlled for the covariates, did not exhibit a
significant association. Prolonged sleep latency, nocturnal awakenings,
hypersomnolence, and sleep duration were not associated with AMD.
A multivariate model was built with independent variables and covariates that
were statistically significant with a p value of < 0.1 based on any of the OLR analyses of
the unadjusted/adjusted models illustrated in Table 11. Independent variables included in
the model were diagnosed sleep apnea, snoring, snorting/stop breathing, and diagnosed
insomnia. Although the p value for any diagnosed sleep disorder met the threshold for
inclusion, this variable was inclusive of the variables for sleep apnea and insomnia (also
included choices of restless leg syndrome and other) and did not present as having as
strong of an association as diagnosed sleep apnea alone. Insomnia was statistically
significant in the unadjusted model and was therefore included. Covariates that were
included in the multivariate model were age, smoking, and BMI. The results of the
multivariate model are presented in Table 12.
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Table 12
Multivariate Model for Association of SDB and AMD
Outcome variable
OR (95% CI)
p Value1
Diagnosed sleep apnea 2.2 (1.1-4.5)
.03
Snoring
1.1 (0.8-1.5)
.45
Snorting/stop
2.4 (1.3-4.5)
.007
breathing
Diagnosed insomnia
1.8 (0.6-5.2)
.30
Age
5.3 (3.5-8.0)
<.001
Smoking
1.1 (0.8-1.3)
.31
BMI
0.9 (0.8-1.1)
.28
1
Based on complex samples ordinal logistic regression.
In the multivariate model, I found significant associations between diagnosed
sleep apnea, snorting/stop breathing, and age; and AMD. Thus, I was able to reject the
null hypothesis associated with RQ 1.
Cox & Snell R2, Nagelkerke R2, and McFadden R2 tests were performed for all
models to compare the relative strength of each model. These are presented in Table 13.
Table 13.
Cox & Snell R2, Nagelkerke R2, and McFadden R2 Values, by Model
Outcome Variable
Cox & Snell R2 Nagelkerke R2 McFadden R2
Any diagnosed sleep
.042
.101
.080
disorder
Diagnosed Sleep Apnea
.043
.103
.082
Snoring
.040
.099
.079
Snorting/Gasping/Stop
.040
.098
.078
breathing
Multivariate Model1
.045
.109
.087
1
Reported for those variables exhibiting a statistically significant (p<.1) association with
AMD severity in Complex Samples Ordinal Logistic Regression models (variables
included in the equation were diagnosed sleep apnea, diagnosed insomnia, snoring,
snorting/gasping/stop breathing, snoring, age, smoking, and BMI).
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Whether I referenced the Cox & Snell R2, Nagelkerke R2, or McFadden R2
methods the pseudo R2 for any diagnosed sleep disorder alone ranges from 4.2% to
10.1%. The pseudo R2 based on the self-reported diagnosis of sleep apnea model ranges
from 4.3% to 10.3%. The pseudo R2 based on the snoring model ranges from 4.0% to
7.9%. The pseudo R2 based on the self-reported snorting/gasping model ranges from
4.0% to 9.8%. The pseudo R2 based on the multivariate model ranges from 4.5% to
10.9%. This suggests that the multivariate model is the strongest one, though none can be
considered predictive.
The assumption of proportional odds was tested in SPSS by performing separate
binomial logistic regressions on cumulative dichotomous dependent variables. NHANES
provides a collapse of Early AMD and Late AMD to form the Any AMD variable as well
as the collapse of the No AMD and Early AMD to form the Late AMD variable. Table 14
summarizes the odds ratios and 95% CI for each independent variable for the two logistic
regression analyses.
Table 14
Proportional Odds Testing: Separate Binomial Logistic Regression Models
Outcome variable
Diagnosed sleep apnea
Snoring
Snorting/stop
breathing
Diagnosed insomnia
Smoking
Age
BMI

No AMD vs. Any AMD
OR (95% CI)1
2.2 (1.1-4.5)
1.1 (0.8-1.5)
2.4 (1.3-4.4)

No Late AMD vs. Late AMD
OR (95% CI)1
NA2
NA2
NA2

1.8 (0.7-5.0)
1.0 (0.6-1.7)
5.5 (3.8-7.9)
1.2 (0.9-1.6)

NA2
NA2
NA2
NA2
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1

Complex Samples Logistic Regression
A quasi-complete separation was detected in the data; therefore the results should be
interpreted with caution.
2

The number of participants in the late AMD category was small and a complete
separation occurred when performing the logistic regression. Therefore, the results should
be interpreted with caution, as the assumption of proportional odds was not met.
Research Question 2 and 3: Complex Samples Logistic Regression
Research questions 2 and 3 were performed to investigate the association of SDB
variables with choroidal neovascularization and geographic atrophy, respectively. Based
on the complete separation that occurred when assessing proportional odds for RQ 1 and
performing logistic regression using Late AMD as the dependent variable, I decided to
collapse the choroidal neovascularization and geographic atrophy variables for analysis.
Combining these variables modified RQ 2 and 3 into the following single research
question:
Research Question 2: Is there an association between self-reported SDB and
fundus photography identified late AMD among adults 40 years and older who
participated in the 2005–2008 NHANES survey after controlling for age, smoking, and
BMI?
H02: There is no association between self-reported SDB and fundus photography
identified late AMD among adults 40 years and older who participated in the NHANES
2005 to 2008 survey after controlling for age, smoking, and BMI.
H12: There is an association between self-reported SDB and fundus photography
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identified late AMD among adult 40 years and older who participated in the NHANES
2005 to 2008 survey after controlling for age, smoking, and BMI.
Late AMD was a variable provided in the NHANES dataset and therefore no
recoding of variables was necessary. The variable for Late AMD (dependent variable)
and the omnibus variable for Any Diagnosed Sleep Disorder (independent variable) were
used to assure model saturation and to address the hypothesis associated with this
question. The results of the Complex Samples Logistic Regression are presented in Table
15.
Table 15
Multivariate Model of the Association of Late AMD and Any Diagnosed Sleep Disorder
Outcome Variable
OR (95% CI)
Any Diagnosed Sleep
0.8 (0.2-4.2)
Disorder
Age
130.8 (16.6-1030.8)
Smoking
0.9 (0.6-1.3)
BMI
0.6 (0.4-1.0)
1
Complex Samples Logistic Regression p < .05

p Value1
.74
<.001
.66
.04

In this model, there was no association of late AMD to any diagnosed sleep
disorder. Thus, I was unable to reject the null hypothesis.
Summary
The first hypothesis tested whether there was an association between self-reported
SDB and fundus photography identified AMD among adults 40 years and older who
participated in the 2005–2008 NHANES survey. Diagnosed sleep apnea, self-reported
snorting/stop breathing, snoring, and diagnosed insomnia were all identified as risk
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factors for AMD based on OLR analyses. A multivariate model that included the
variables sleep apnea, self-reported snorting/stop breathing, snoring, diagnosed insomnia,
age, and BMI provided the best model fit. However, the results should be interpreted with
caution, as the assumption of proportional odds was not met. The second and third
hypotheses of an association between self-reported SDB and choroidal
neovascularization or geographic atrophy, respectively had to be collapsed based on the
small sample size of these late AMD subpopulations. Therefore, the second hypothesis
that was tested was the association of any diagnosed sleep disorder with late AMD. There
was no association between any diagnosed sleep disorder and late AMD based on binary
logistic regression.
I provide a detailed interpretation of the results in Chapter 5 and a comparison of
these results to evidence available with regards to the association between SDB and
AMD in the current literature. The limitations and strengths of the study will be
evaluated. Lastly, recommendations for additional research as well as the potential
impact that these research findings may have on social change and public health will be
discussed.
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Chapter 5: Discussion
Introduction
By the year 2050, the estimated number of people with AMD in the United States
is expected to more than double, from 2.07 million to 5.44 million (National Eye
Institute, 2016a). Although there has been much progress over the last decade in
understanding the etiology of AMD, an understanding of the factors associated with the
development and/or progression of AMD is still missing.
In this study, quantitative data from the 2005–2008 NHANES survey were used
to explore the association between SDB and AMD. SDB has been shown to interfere with
current anti-VEGF treatments for neovascular AMD. Barak et al. (2012) reported that
OSA hampered the response to anti-VEGF therapy for the treatment of neovascular
AMD. Khurana et al. (2016) demonstrated that sleeping more than 8 hours a day was
associated with geographic atrophy. These results were also corroborated by research
from Perez-Canales et al. (2016), who found a statistically significant association
between sleep duration and AMD. In addition, Keenan et al. (2016) reported that OSA
was positively associated with AMD. To date, there have been no published studies of
population-based research on the association between various SDB measures and AMD.
In Chapter 5, I interpret my findings in relation to those of previous studies and
the life course theory. I discuss the limitations of this research and suggest future research
that is needed to address those limitations. Finally, I discuss the significance of this
research in terms of its significance and potential to contribute to positive social change.
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Interpretation of Findings
According to the findings of this study, SDB is associated with AMD. The
association of a number of SDB variables with AMD remained statistically significant
even after controlling for the sociodemographic characteristics of age, smoking status,
and BMI. This is the first known? study on the association of numerous SDB
characteristics with AMD in a nationally representative population of the United States.
Study Sample and Sociodemographic Characteristics
This study evaluated potential sociodemographic characteristics that could be
relevant to investigating the association between SDB and AMD using a nationally
representative sample. The NHANES sample from 2005–2008 was oversampled for
certain race/ethnicity groups, namely Mexican Americans and Hispanics. The analysis I
performed indicated that there is a statistically significant difference in race/ethnicity
between the NHANES sample and the study sample. This is likely explained by the fact
that fewer Mexican Americans had their retinal photos obtained because only 22% of the
population was over the age of 40. To account for this oversampling, all analyses were
performed using the weighting factors provided by NHANES.
Preliminary chi-square analysis was performed to understand the association
between AMD and the predefined sociodemographic characteristics (see Table 9). Age,
race/ethnicity, smoking status, and BMI illustrated a statistically significant relationship
with AMD. This was not unexpected because risk factors for AMD have been previously
reported in the peer-reviewed literature: increasing age (E. Chew et al., 2014; Tomany et
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al., 2004), non-Hispanic White race/ethnicity (T. Wong et al., 2002), past/current
smoking status (E. Chew et al., 2014), and elevated BMI (Q. Zhang et al., 2016). There
was a clear difference in the age categorizations of the population of participants without
AMD as compared to those with AMD. In the group of participants without AMD, 47%
of participants were >60 years of age, while in the group of participants with AMD 83%
were >60 years of age. The population of non-Hispanic White in the AMD population
was 71% compared to 53% in the population without AMD. Conversely, there were
fewer non-Hispanic Black participants (8%) in the population with AMD as compared to
those without AMD (21%). These racial/ethnic differences are consistent with previous
reports from NHANES as well as other epidemiological studies, though with the addition
to the model of the SDB variables, the observed association was negated (Klein et al.,
2011; Klein, Clegg, et al., 1999; Klein, Klein, et al., 1999; Klein et al., 2006). The
number of current smokers in the population with AMD was 15%, while 21% of
participants with no signs of AMD reported currently smoking. The number of current
smokers in the 40-59-year-old category was 27%, while there were only 13% current
smokers in the ≥ 60-year-old category. These findings are consistent with current CDC
data showing that fewer people aged ≥65 are current smokers (Jamal et al., 2015). The
number of participants reporting as a past smoker in the ≥ 60-year-old category was 42%,
outweighing the 23% in the 40-59-year-old category responding as past smokers. In these
analyses, past smokers were defined as anyone who smoked over 100 cigarettes in their
lifetime. This definition allows for a significant amount of potential variation within the
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group as it pertains to the overall exposure (packs of cigarettes smoked, years of
smoking, etc.) to the harmful effects of smoking.
There was no apparent association with gender or diabetes status in the study
sample. Those sociodemographic characteristics that illustrated a statistically significant
association (p < 0.1) with AMD were included in adjusted models for all SDB
characteristics as well as multivariate models.
As the study sample consisted of all available participants in an attempt to be able
to study the smaller late AMD population, it was important to investigate whether the
study sample was representative of the NHANES sample. A chi-square Goodness of Fit
was performed to assess whether the study sample was similar to the overall NHANES
sample as it pertained to these characteristics. Only gender and smoking status were
found to reflect the NHANES sample. The other characteristics were statistically
significant illustrating a dissimilar distribution in both populations. As age and BMI are
included in the multivariate analysis and weighting is based on the original sample, I
must use caution when interpreting the association of these variables to AMD.
Association of SDB with AMD
Preliminary chi-square analysis was performed to investigate the association of a
number of SDB characteristics with AMD (Table 10). There was a statistically significant
association with AMD in participants that self-reported a doctors’ diagnosis of any sleep
disorder or sleep apnea. In addition, there was a statistically significant association with
AMD in those participants reporting snorting, gasping, or cessation of breathing. There
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were no associations between AMD and snoring, insomnia, prolonged sleep latency,
nocturnal awakenings, hypersomnolence or sleep duration. Regardless of association,
SDB variables were included in both adjusted and unadjusted OLR models.
Any sleep disorder. SDB variables were analyzed using Complex Samples OLR
models (Table 10). Those participants with any self-reported diagnosed sleep disorder
(sleep apnea, insomnia, restless leg syndrome, or other) were two times (OR, 2.2; 95%
CI, 1.2-3.9) more likely to have AMD than those without a diagnosed sleep disorder. This
is the first report of an association with an open-ended query for any diagnosed sleep
disorders from a population based sample. The association remained statistically
significant even after adjustment for covariates (age, smoking status, and BMI). As the
understanding and identification of sleep disorders has evolved and improved over the
last decade, it is possible that the number of participants with diagnosed sleep disorders is
low during the 2005–2008 survey periods as compared to more recent sampling frames.
The HypnoLaus study that collected data from 2009-2013 reported SDB prevalence to be
as high as 49% and 23% of men and women in Switzerland, respectively (Heinzer et al.,
2015). It has been postulated that this higher prevalence is due to the improved sensitivity
of SDB recording techniques and to a newer definition of respiratory events (particularly
the hypopnea definition) (Heinzer, 2016).
Sleep apnea. Sleep apnea has been previously reported to be associated with
AMD in a large national health service cohort in the United Kingdom (Keenan et al.,
2016). The current study based on the U.S. population corroborates these findings with
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those with a diagnosis of sleep apnea 2.6 times (OR, 2.6; 95% CI, 1.4-5.1) more likely to
develop AMD as compared to those participants without diagnosed sleep apnea. The
odds of having AMD in participants with sleep apnea remained unchanged even after
adjustment for sociodemographic variables. Fraser et al. (2013) performed a prospective
fundus photographic study of patients undergoing PSG in a community sleep center.
Retinal vascular changes were much more common in patients with sleep apnea, even
after controlling for history of diagnosed hypertension (Fraser et al., 2013). AHI>40
conferred a doubling of the odds of retinal vascular changes as compared to those with
AHI<5, even after controlling for confounding variables. Research by Nesmith et al.
(2014) provided some insight into an underlying mechanism whereby sleep apnea is
shown to exert pathological changes on the underlying retinal vasculature. In their study,
the researchers investigated patients that were refractory (defined as persistent subretinal
fluid after 3 consecutive injections) to treatment with anti-VEGF medications, the current
standard of care for neovascular AMD. VEGF blocking agents have been shown to exert
their effects on the retina by reducing vascular permeability and improving retinal edema
and subretinal fluid (CATT Research Group, 2011). The result that more patients with
OSA in this study were found to have refractory subretinal fluid indicated that sleep
apnea modifies retinal vascular permeability despite anti-VEGF therapy. This same
phenomenon was noted by Barak et al. (2012) who also noted that the fluid accumulation
could be reversed once CPAP therapy for sleep apnea was initiated.
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One potential theory to explain the underlying etiology of this phenomenon is the
presence of circulating inflammatory proteins. Zychowski et al. (2016) incubated human
endothelial cells with serum from patients with sleep apnea and healthy controls. In
patients with sleep apnea, the cell cultures resulted in greater serum inflammatory
potential, thereby driving endothelial activation/dysfunction (Zychowski et al., 2016).
Importantly, collecting serum from the same sleep apnea patients after initiation of CPAP
therapy resulted in a reduction in endothelial cell inflammatory potential and
activation/dysfunction. Sleep apnea is a chronic disease that goes undiagnosed in much of
the affected population, sometimes for decades. Chronically exposing the vulnerable
retina vasculature to recurrent hypoxia, resulting in persistent circulating inflammatory
proteins, may explain the underlying cause for the association evident in this study.
Insomnia and Sleep Duration. This study is the first to look directly at the
association of diagnosed insomnia with AMD. In the study sample, those with diagnosed
insomnia were three times (OR, 3.1; 95% CI, 1.1-9.0) as likely to have AMD as those
without a diagnosis of insomnia. When adjusted for sociodemographic characteristics,
diagnosed insomnia no longer had a statistically significant association with AMD.
Interestingly, insomnia has been associated with neurodegenerative disorders such as
Alzheimer’s and Parkinson’s disease and the deposition of Aβ (Keene & Joiner, 2015).
With Aβ deposition noted as a drusen component, I must consider the possibility that
similar mechanisms could be at play with AMD pathogenesis promoted by SDB.
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In this study, sleep duration did not demonstrate a statistically significant
association with AMD. In the literature, AMD was shown to be associated with sleep
duration, although the reports in the literature have been specific to geographic atrophy
and choroidal neovascularization, and not early AMD (Khurana et al., 2016; PerezCanales et al., 2016). The findings from the current study may be consistent with the
literature reported associations with late AMD, although the OLR modelling was not
designed to answer this question. In addition, there were a very small number of
participants with late AMD in the study sample. I will discuss this lack of participants in
the study sample with fundus photograph identified late AMD in more detail as it pertains
to RQ 2.
Snorting/Gasping/Stop Breathing and Snoring. Snorting/Gasping/Stopping
breathing during sleep is representative of a decrease in oxygen saturation that stimulates
arousal and can be quantified using AHI scores. AHI values have been associated with a
reduction in RNFL thickness (Huseyinoglu et al., 2014; Shiba et al., 2014).
Snorting/Gasping/Stopping Breathing in this study was statistically significant for an
association with AMD, illustrating a three (OR, 2.8; 95% CI, 1.3-6.0) times greater odds
of having AMD. This continued to be statistically significant even after adjusting for
covariates. Snoring was also significantly associated with AMD, introducing a 1.5 times
(OR, 1.5; 95% CI, 1.1-2.0) greater likelihood of AMD. Snoring did not remain
statistically significant after adjusting for covariates.

113
Prolonged Sleep Latency, Nocturnal Awakenings and Hypersomnolence.
Prolonged sleep latency, nocturnal awakenings, and hypersomnolence, were not
associated with AMD. The responses to these survey questions may be subject to
significant recall bias as the answers may not be as easy to remember as compared to
answering whether there was a previous doctor’s diagnosis of sleep disorders such as
sleep apnea or insomnia. Therefore, it is hard to interpret whether the lack of association
is accurate, or if the instrument was not sensitive enough to detect the association.
Sociodemographic Characteristics
Age. As expected, increased age was highly statistically associated with AMD in
all models. In the current study, using multivariate OLR modelling, age ≥60 conferred
more than five times the likelihood of developing AMD as compared to those in the 4559-year-old category. The increased odds associated with increasing age were consistent
and statistically significant across all adjusted models and in multivariate modelling.
Even with the advent of anti-VEGF therapy, AMD is a leading cause of permanent
blindness in adults aged 60 and older in the United States, and present in more than 14%
of White Americans over the age of 80 (NEI, 2016a).
Smoking. Smoking has been consistently shown in the literature to be the most
strongly associated modifiable risk factor for AMD (E. Chew et al., 2014; Evans,
Fletcher, & Wormald, 2005). In this study, smoking was strongly associated AMD when
assessed using the chi-square test of association (p < .001). When smoking was
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incorporated into multivariate models, the OR was 1.1 indicating a non-statistically
significant contribution to the prediction of AMD.
BMI. BMI has previously been shown to be mildly associated with AMD (Q.
Zhang et al., 2016) and significantly associated with SDB (Heinzer et al., 2015). In this
study, BMI was associated with AMD when assessed using the chi-square test of
association (p < .02). When BMI was incorporated into the multivariate models this
statistically significant association with AMD was negated.
Multivariate Modelling. Multivariate modelling was performed on independent
variables and covariates that demonstrated a statistically significant association (P<0.1)
with chi-square tests of association and/or OLR. A model was built that included
diagnosed sleep apnea, diagnosed insomnia, snoring, snorting/gasping/stop breathing, and
snoring as independent variables. Age, smoking status, and BMI were included as
covariates. The multivariate model provided the best model fit compared to all other
univariate models.
Association of SDB with Late AMD
Keenan et al. (2016) demonstrated an association between AMD and sleep apnea
in a record linkage study from the United Kingdom. Based on this data, and the findings
from Fraser et al. (2013) that illustrated increased prevalence of vascular changes with
sleep apnea, I hypothesized that sleep apnea may be associated with choroidal
neovascularization. Additionally, Khurana et al. (2016) have shown an association with
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sleep duration and geographic atrophy, so it is plausible that a diagnosed sleep disorder
may have an association with atrophic changes in the retina.
The prevalence of AMD in the study sample was 6.9%, consistent with estimates
from the same survey periods previously reported by Klein et al (2011). Late AMD was
present in only 1.0% of the sample; therefore, adjustments were made to the original
analysis plan which divided choroidal neovascularization and geographic atrophy into
separate research questions. As the presence of late AMD disease was so rare in the study
sample, I collapsed the choroidal neovascularization and geographic atrophy categories to
form a single late AMD variable for analyses. Similarly, the omnibus variable for any
diagnosed sleep disorder (NHANES questionnaire choices included sleep apnea,
insomnia, restless leg syndrome, and other) was used in the analysis to assure model
saturation. The model included the covariates of age, smoking status, and BMI as used in
the OLR analyses. There was no association found with any diagnosed sleep disorder and
AMD. Based on a post-hoc power calculation, it would take approximately 1039
participants to detect a moderate OR of 1.5. Therefore, it is likely that the available
number of participants in the study sample with late AMD (n=55) was not robust enough
to provide the power to detect an association.
Overall Findings
In using the life course theory of chronic disease as the framework for this
quantitative cross-sectional study, I was able to find significant associations between a
number of SDB variables and AMD. Although the OLR analyses did not meet the
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assumption of proportional odds due to the small number of participants with late AMD,
the ORs from the OLR were almost identical when performing separate binomial logistic
regression for any AMD. These findings provide confidence that the interpretation of
association is valid and that it is primarily driven by the participants with early AMD in
this sample. The application of the life course theory of chronic disease in this study
posited that SDB would have a temporal relationship with presentation of early AMD in
exposed participants. As previously stated, there is a temporal relationship between the
age of peak presentation of SDB and the age at which signs associated with early AMD
are evident (Bixler et al., 1998; Bourne et al., 2014). The findings of the current study
implicated SDB as a factor along the life course of the AMD patient and represent
another modifiable risk factor that could be addressed with public health intervention.
There are several strengths of the current study. First, the dependent variable for
AMD was assessed using independent grading of retinal photographs. This allowed for a
highly objective measure to assess AMD classification and eliminated participant recall
biases that would be present if this data was collected from a questionnaire. Second, the
study participants are a nationally representative sample of the U.S. civilian noninstitutionalized population from the NHANES 2005–2008 survey. The sample has a
nearly equal distribution of men and women and has been over-sampled to allow for an
assessment of association in under-represented racial/ethnic groups. The multi-stage
sampling scheme employed by NHANEs may reduce the referral biases that have been
noted in studies using sleep-clinic based populations (Seicean et al., 2011). Lastly, a
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robust set of statistical analyses was performed by applying chi-square, OLR, and
multivariate logistic regression analyses to examine the associations between AMD and
SDB.
Limitations of the Study
There are several limitations to this study. The NHANES survey is a crosssectional survey by design, and therefore the data was collected at one single point in
time. Due to this limitation, longitudinal trends in health behavior cannot be examined.
This study is correlational in nature, and as such, care must be taken when interpreting
the results. Although statistically significant associations were identified between AMD,
SDB-related variables, and other covariates; causality cannot be assessed.
Although one of the strengths of this study is that the AMD variable was assessed
by independent photography graders using a standardized protocol and definitions for
findings, the SDB variables were all questionnaire derived. Recall bias may have led to
misclassification of participants that could have impacted my results. The gold standards
for defining SDB are an airway evaluation with an accompanying polysomnographic
(overnight sleep study) assessment. This would have been a more objective measure of
SDB as compared to questionnaire data, although this is not part of the examinations
offered for NHANES, likely due to its inherently high cost.
The NHANES survey is a useful tool to assess the health of the U.S. population.
One of the limitations of the survey is that data collection is limited to civilian, noninstitutionalized U.S. citizens (CDC, 2011). Therefore, the results of this study cannot be
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generalized to the non-civilian or institutionalized populations of the United States or
abroad. With AMD primarily affecting the elderly, the institutionalized population may
be an important population to consider in future attempts to understand the true
magnitude of the association between SDB and AMD.
There were a number of limitations based on the composition of the study sample.
First and foremost, the small number of participants with late AMD required a
modification of the analysis plan. Additionally, not all participants participated in the
MEC acquisition of fundus photos. Although the sample that had fundus photography
performed was similar in sociodemographic characteristics to the sample that did not
have photos taken, the exclusion of those without this exam reduced the available sample
size and therefore my power to detect significant differences. Some of the reasons for not
having photos taken included participants having no light perception, severe visual
impairment in both eyes, or an infection in at least one eye (CDC, 2005). Those
participants with no light perception or severe visual impairment in both eyes may have
actually had AMD, and likely late AMD, and therefore may have reduced the available
number of cases with disease in the data set.
In the 2005–2008 sampling timeframes, there were a number of ethnic and age
groups oversampled in NHANES (National Center for Health Statistics [U.S.], 2013).
Although this may have allowed for better estimation of association in these groups, it is
possible that this oversampling could have had unseen adverse consequences with regard
to the results of the non-Hispanic White group that has the highest prevalence of AMD in
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the U.S. population. The NHANES survey may not contain a representative sample of
some ethnic groups as the data collected included Non-Hispanic Whites, Non-Hispanic
Blacks, Mexican-Americans, other Hispanic, and all other groups are lumped into the
“Other Race” category (Johnson et al., 2013). Therefore, certain ethnic groups such as
Asian-Americans are not represented in the dataset and the association with SDB and
AMD is unable to be assessed. While weighting is available to adjust for the sampling
scheme, it is based on the full and not the reduced sample I was able to use for this
sample.
Lastly, the assumption of proportional odds was not met when performing OLR
analyses. Separate binomial logistic regressions were performed using cumulative
dichotomous dependent variables to test this assumption. It was clear that the number of
participants in the “Late AMD” category was too small to support the assumption of
proportional odds and therefore the ordinal nature of the dependent variable was lost. By
collapsing the AMD category into “Any AMD” the ORs for the association of SDB
variables and AMD were able to be calculated meeting all assumptions of this analysis.
In interpreting the results of this study, I recognized that the resultant ORs were driven
primarily by participants with early AMD and not late AMD.
Recommendations
Although the study indicated that there is a statistically significant association
between SDB and AMD, I was unable to investigate causality. Future research should be
performed to define the causal link between SDB and AMD. The collection of
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longitudinal data starting with an early diagnosis of SDB by polysomnography in
individuals under the age of 50 followed by regularly scheduled retinal examination
and/or diagnostic imaging would further enhance the body of research available on SDB
and AMD.
The understanding of this association would be further enhanced by diagnosis of
SDB by more objective sleep quality measures such as polysomnography instead of
participants responding to a questionnaire. Young et al. (1997) have shown that as many
as 82% of men and 92% of women with SDB are undiagnosed and therefore a study with
a large cohort screened by polysomnography could provide more accurate classification
of SDB as compared to the current study. When coupled with independently graded
retinal photography, this screening could provide a powerful, albeit costly, dataset for
answering this important research question.
I was unable to investigate the association between SDB and choroidal
neovascularization or geographic atrophy. Future research should be directed at
understanding the association in those participants who develop late AMD. Among the
group of subjects that present with choroidal neovascularization with SDB the data
suggests a higher incidence of retinal vascular abnormalities; this warrants further
evaluation in an enriched population.
This study used data from the most recent NHANES survey periods where retinal
photography was incorporated. In contrast, the sleep questionnaire has been administered
a number of times from 2005-2014. Future research could include retinal photography as
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a part of examination data in conjunction with the sleep questionnaire to allow this study
to be replicated. In addition, current NHANES questionnaires include non-Hispanic
Asian as an ethnic/race category, therefore the association between SDB and AMD could
be investigated in the Asian population.
Implications
The findings from this study have the potential to have a profound and positive
impact on social change. AMD prevalence is expected to double in the next three decades
(NEI, 2016b). It is estimated that the global cost of visual impairment due to AMD is
$343 billion, including $255 billion in direct health care costs (BrightFocus Foundation,
2016). The ability to prevent AMD represents a significant opportunity for saving
healthcare costs in the United States and other industrialized countries. Currently, there
are no therapies proven to prevent AMD, only to treat AMD symptoms once diagnosed.
Potential modifiable risk factors that have shown some promise in reducing AMD
incidence include diet and smoking. SDB represents a third modifiable risk factor that if
diagnosed and treated could have an impact on new cases of AMD. Public health
programs that develop SDB screening guidelines and subsequently promote treatment
compliance could have a major impact on AMD and a number of other potential
complications of SDB.
At the individual patient level, SDB diagnosis rates as well as CPAP treatment
compliance are notoriously poor. Public health practitioners may choose to use the fear of
blindness as a motivating factor to get patients to get screened for SDB as well as to
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promote continued adherence to CPAP therapy. Improving screening of SDB patients and
adherence to SDB therapy of specific individuals and at-risk populations will aid the
public health community in meeting the objectives for Healthy People 2020, specifically
to reduce vision impairment due to AMD (Office of Disease Prevention and Health
Promotion, 2016).
Currently, sleep medicine practitioners and retina specialists do not co-manage
patients. The current guideline for OSA states that disease management should be as a
chronic condition, using a multidisciplinary approach (Epstein et al., 2009). However,
there is no mention of ophthalmology and/or eye health in the OSA guidance. This study,
in addition to those aforementioned in the literature review, creates a growing body of
evidence that SDB is associated with AMD and can have a negative impact on treatment
outcomes for patients with AMD. The current Preferred Practice Patterns for AMD
published by the American Academy of Ophthalmology (AAO) mentions a number of
risk factors for AMD although SDB was not listed as one of them (AAO, 2015).
Increasing healthcare practitioners’ understanding of the association of SDB and AMD
may encourage their incorporation of screening and preventative measures into delivery
of care guidelines.
Conclusions
Based on my extensive literature review, I believe this was the first research study
to investigate the association between SDB and AMD in a civilian, non-institutionalized
population of the United States. The results from this cross-sectional study suggest that
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AMD is associated with diagnosed sleep disorders including sleep apnea and insomnia,
as well as sleep apnea symptoms (snorting/gasping/stop breathing and snoring).
Furthermore, these associations were independent of sociodemographic and lifestyle
factors. AMD can be added to the growing list of chronic diseases that have been linked
to SDB such as cardiovascular disease and Alzheimer’s disease.
Future research should aim to look at the association of SDB with late AMD
(choroidal neovascularization and geographic atrophy). Study designs should employ the
most objective measures available for assessing SDB (polysomnography) and AMD
(multimodal retinal diagnostic imaging). Additionally, research is needed to determine
causal relationships that will help direct interventional and preventative public health
programs.
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